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CHAPTER I 
 
INTRODUCTION 
 
Diabetes mellitus, a metabolic disease in which hyperglycemia is the primary symptom, 
is estimated to affect approximately 25.8 million people in the United States, or 8.3% of the 
American population (CDC, 2011).  Now being considered an epidemic and a major health-care 
burden (CDC, 2011), diabetes confers a risk of greater morbidity (e.g. retinopathy, neuropathy, 
nephropathy, cardiovascular disease) and mortality in persons afflicted with the disease (de 
Groot, Anderson, Freedland, Clouse, & Lustman, 2001; X. Zhang et al., 2005).   
Diabetes has also been noted to have an association with depression, as persons with 
diabetes may have a 2-3 times greater chance of having depression than the general population 
(Anderson, Freedland, Clouse, & Lustman, 2001; Gavard, Lustman, & Clouse, 
1993).  Depression in diabetes patients has also been linked to a number of detrimental 
outcomes:  poor glycemic control (Lustman & Clouse, 2005), poor dietary compliance and 
adherence to medications (Ciechanowski, Katon, & Russo, 2000; Lin et al., 2004), increased 
health care expenditures (Ciechanowski et al., 2000), increased risk for a variety of diabetes 
complications (de Groot et al., 2001; van Steenbergen-Weijenburg et al., 2011) and increased 
mortality (X. Zhang et al., 2005).   
There are two prevailing hypotheses that attempt to explain the presence of significant 
depression in persons with diabetes.  First, depression may develop as a result of psychosocial 
aspects of having diabetes, including the psychological demands of managing the disease, the 
daily burden of self-care behaviors and the long-term risk of serious complications.  Second, an 
underlying biological mechanism may play a role in the association, such as a dysregulation of 
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the hypothalamus-pituitary-adrenal (HPA) axis or changes in hippocampal functioning.  This 
study will focus primarily on the psychological aspects of the disease.  More specifically, this 
study examines how patients cope with diabetes and disease management, and how coping 
strategies (e.g. primary and secondary engagement coping, disengagement coping) used to 
manage various aspects of this chronic illness may play a role in psychological outcomes.   
Prior studies examining the role of coping and depression in diabetes patients have 
revealed several key findings.  Primarily, problem-focused coping has been associated with 
fewer depressive symptoms, while avoidance has been associated with higher rates of depressive 
symptoms (Smari & Valtysdottir, 1997).  Studies examining emotion-focused coping strategies 
have found variable results; some studies found emotion-focused coping to be positively 
correlated with depressive symptomatology, while other studies showed the opposite result 
(Duangdao & Roesch, 2008).  However, measures previously used to assess coping may have 
had methodological issues that confounded these findings.  Some measures failed to adequately 
distinguish between adaptive and maladaptive coping strategies related to emotions, while other 
measures assessed general coping rather than illness-specific coping strategies.  A newer 
measure of coping, the Responses to Stress Questionnaire (RSQ), may shed new light on coping 
in patients with diabetes.    
The proposed study will attempt to examine illness-specific coping strategies in 
relationship to depression using the RSQ in a sample of type 2 diabetes patients.  Additionally, 
coping styles and depressive symptoms will be examined in relationship to diabetes-related 
distress and self-care behaviors in persons with type 2 diabetes.  Finally, a confirmatory factor 
analysis will be performed to validate the RSQ in a sample of adult diabetes patients. 
 
  
3 
 
 
Diabetes 
Overview   
Diabetes is a chronic illness found in approximately 25.8 million children and adults in 
the United States, affecting approximately 8.3% of the American population.  However, of those 
25.8 million people, an estimated 7.0 million people remain undiagnosed (CDC, 2011)  Diabetes 
differentially affects racial and ethnic groups, with African-Americans, Hispanics, Asians, 
Pacific Islanders and Native Americans being at highest risk for developing type 2 
diabetes.  Complications from diabetes include kidney failure, blindness, neuropathy and non-
traumatic limb amputations, among others.  In 2007, diabetes was the seventh leading cause of 
death listed on U.S. death certificates. However, diabetes is also likely to be underreported as a 
cause of death.  Estimates suggest that the risk for early death among people with diabetes is 
about two times greater than the mortality risk of their non-diabetic counterparts (CDC, 2011).    
Diabetes occurs when there is a dysfunction of either the use or production of insulin in 
the body.  Insulin, produced by beta cells in the pancreas, is a hormone that is required for 
carbohydrate metabolism.  Insulin directly affects cellular uptake of glucose from the 
bloodstream.  As glucose is a primary energy source, insulin is critical for human 
survival.  Insulin also plays a role in glycogen synthesis, fatty acid synthesis, lipolysis and 
gluconeogenesis.  There are differential effects of insulin and insulin production in persons with 
diabetes, resulting in the categorization of type 1 and type 2 diabetes (Saudek, 1997).     
Type 1 diabetes (insulin-dependent diabetes mellitus), formerly known as juvenile 
diabetes, results as a function of pancreatic cell failure and insulin deficiency. The onset of type 
1 diabetes typically occurs during childhood and adolescence, though type 1 diabetes has also 
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been diagnosed in older adults.  Persons with type 1 diabetes are treated with insulin replacement 
therapy, wherein synthetic insulin is administered either by periodic injections or an insulin 
pump.   Patients must account for their carbohydrate intake and activity levels when determining 
the amount of insulin that they receive; too much insulin may cause dangerously low blood sugar 
levels (hypoglycemia), while too little insulin may cause a spike in blood sugar levels 
(hyperglycemia), possibly leading to ketoacidosis.  Persons with type 1 diabetes are more at risk 
for an acute diabetic crisis via blood sugar levels that are either too low or too high.  The risk of 
long-term complications is also increased in this population, particularly when accompanied by 
persistent hyperglycemia (Saudek, 1997). 
Type 2 diabetes (non-insulin dependent diabetes mellitus) is currently the most common 
form of diabetes and accounts for up to 90-95% of all cases of diabetes in North America (CDC, 
2011).  Type 2 diabetes is characterized by insulin resistance and decreased insulin production, 
wherein the pancreatic cells do not produce enough insulin and target cell receptors do not 
respond appropriately to the presence of insulin.  The result of decreased insulin production and 
insulin resistance is chronically elevated blood sugar levels (hyperglycemia).  The 
pathophysiology of type 2 diabetes is complex. Certain factors, such as inadequate exercise and 
poor diet, the presence of obesity, the metabolic syndrome, insulin resistance and a familial 
history of diabetes are associated with a risk of developing type 2 diabetes (Kahn, Hull, & 
Utzschneider, 2006).  
Although there are no methods to prevent or cure Type 2 diabetes, type 2 diabetes may be 
managed effectively through diet and exercise, as a balanced diet and increased activity levels 
can reduce insulin resistance.  However, when the disease becomes more advanced, a person 
with type 2 diabetes may take oral medications or insulin injections to help control their 
  
5 
 
diabetes.  Adhering to an appropriate regimen of diet and exercise may control the illness 
without the individual ever becoming dependent on insulin. Ketoacidosis does not occur as 
frequently in persons with type 2 diabetes, thus the chances of an acute diabetic crisis due to 
hyperglycemia is somewhat reduced in this population.  However, exposure to chronically-
elevated blood glucose levels can cause damage to tissues and organs throughout the body, 
resulting in an elevated risk of morbidity and mortality (Saudek, 1997).   Hypoglycemia, or 
abnormally low blood sugar, is still a concern in type 2 diabetes.  
Previously type 2 diabetes has been known as “adult-onset” diabetes, as it typically 
affected adults in their late 40–50s.  However, type 2 diabetes is increasingly becoming a health 
problem for adolescents and young adults in the United States (CDC, 2011).  
 
Disease burden and complications 
Having diabetes is a source of stress, as a person with diabetes may experience many 
daily and long-term difficulties as a result of the disease.  A diabetes patient's daily regimen may 
include multiple blood glucose tests, careful monitoring of dietary carbohydrate intake, 
administration of oral or injectable medication, monitoring of symptoms of low or high blood 
sugar, and adherence to an exercise program. Attention to diabetes can require a great deal of 
time, not only with moment-to-moment decisions about diet, medication and exercise, but also 
with frequent doctor's office and hospital visits.  Diabetes has a financial impact on the patient; 
diabetes self-care can be extremely expensive.  Health care costs for patients with diabetes are 
estimated to equal approximately $11,744 per year, of which $6,649 is attributed to diabetes 
(ADA, 2008). Thus, the patient must adjust to far-reaching lifestyle changes after diagnosis with 
diabetes.   
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Furthermore, having diabetes increases the risk of long-term complications from the 
disease.  Diabetic complications include diabetic neuropathy (nerve damage and pain), 
nephropathy (kidney damage), retinopathy (blindness), wounds that fail to heal, a higher risk of 
stroke and a higher risk of cardiovascular disease (CDC, 2011).  Presence of these complications 
can cause both physical and emotional distress to the diabetes patient, increasing the risk of 
mortality (Young et al., 2008) and compromising quality of life (Wexler et al., 
2006).  Management of this chronic illness, and particularly the routine management of common 
daily stressors, is critical to these individuals’ physical and psychological health.     
 
Depression 
Depression is a psychological disorder that affects millions of people worldwide (WHO, 
2001).   In addition to causing both emotional and physical distress, depression is also cited as 
one of the leading causes of disability (WHO, 2001).  Depressive symptoms may include mood 
disturbances, anhedonia, changes in weight, appetite or sleep patterns, low energy, psychomotor 
disturbances, feelings of guilt or worthlessness, poor concentration and recurrent thoughts of 
death or suicide (NIMH, 2011).  Symptoms of depression can range from mild to severe, have 
varying impacts on daily functioning and have different temporal characteristics.  A depressive 
state can occur in reaction to an acute stressor, multiple stressors, or no apparent cause, 
producing a brief disturbance in mood, cognitions and behavior.  However, a mood disturbance 
may be classified as a disorder if it remains unresolved over time and is coupled with multiple 
depressive symptoms.   
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Epidemiology, etiology and treatment 
Major Depressive Disorder (MDD) is relatively common in the general population 
though prevalence estimates in the United States have varied results.  Some studies estimate 
lifetime prevalence rates of MDD to be 3.0% to 5.9%, with 12-months rates being estimated as 
1.7% to 3.4% (L. Robins & Regier, 1991), while others found much higher rates of MDD (14.9% 
for lifetime and 8.6% for 12-month) (Kessler et al., 1994).  More recent data from the National 
Comorbidity Survey Replication (NCS-R) suggested that the lifetime prevalence of MDD in the 
United States is approximately 16.2% with a 12-month prevalence estimate of 6.6% (Kessler et 
al., 2003).   
The etiology of depression is complex, varied and not yet fully understood.  Biological 
and psychosocial factors are both implicated in the development of depression, yet these factors 
may vary between individuals and types of depression.  Many theories of depression propose a 
diathesis-stress model, in which a stressor interacts with an individual's biological or cognitive 
vulnerability to produce a depressive reaction.  The severity and temporal characteristics of the 
stressor(s), as well as the individual's biological and genetic makeup (Caspi et al., 2003), use of 
coping skills (Matheson & Anisman, 2003), cognitive style (Alloy et al., 2000; Scher, Ingram, & 
Segal, 2005), and degree of social support (George, Blazer, Hughes, & Fowler, 1989; Gladstone, 
Parker, Malhi, & Wilhelm, 2007), may contribute to the development of depression.   
Several psychosocial factors have been associated with a higher risk of depression, 
including gender, socioeconomic status, marital status, social support and age.  More women 
than men will be affected by depression in their lifetime; the risk of depression is approximately 
two times greater in women versus men (NIMH, 2005; Nolen-Hoeksema, 1987; Nolen-
Hoeksema & Girgus, 1994).  Persons in lower socioeconomic groups have a much greater risk of 
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depression than those in higher social and economic classes (Adler et al., 1994).  Persons who 
are married and perceive themselves as having a larger social network are less likely to be 
depressed (George et al., 1989; Simon, 2002).   
 
Diagnosing depression 
Depression may be assessed by a clinician or a trained professional, using either a semi-
structured interview such as the Structured Clinical Interview for DSM-IV (SCID) (Spitzer 
(Spitzer, 1992), the Hamilton Rating Scale for Depression (Hamilton, 1960), the Diagnostic 
Interview Schedule (DIS) (L Robins, Helzer, Croughan, & Ratcliff, 1981), or the Composite 
International Diagnostic Interview (CIDI)  (Kessler et al., 1994).   
In the absence of a clinical interview, depression may be measured by self-report, using 
instruments such as the Beck Depression Inventory (BDI) (Beck, Ward, Mendelson, Mock, & 
Erbaugh, 1961), the Center for Epidemiological Studies Depression Scale (CES-D) (Radloff, 
1977), the PHQ-9 (Kronenke, 2001), and the Zung Self-Rating Depression Scale (Zung, 1965). 
Cutoff points are used to estimate probable cases of depression with these measures.   
  
Comorbidity between Diabetes and Depression 
Recognizing and treating depression is particularly critical to the health and quality of life 
of a person living with diabetes.   Comorbid depression has been linked to adverse outcomes in 
diabetes patients, including increased health care expenditures (Ciechanowski et al., 2000), poor 
glycemic control (Lustman & Clouse, 2005; Papelbaum et al., 2011), decreased adherence to 
medical treatment (Lustman, Griffith, & Clouse, 1988), an increased risk of morbidity and an 
increased risk of mortality (de Groot et al., 2001; X. Zhang et al., 2005).  As a result, prevention 
  
9 
 
and treatment of depression may be particularly important in persons with diabetes or persons 
who are at risk for later development of type 2 diabetes. 
 
Prevalence of depression in patients with diabetes 
Two primary meta-analyses have established the current view on prevalence rates of 
depression among people with diabetes.  The first, authored by Gavard and colleagues (1993), 
examined the results of 20 epidemiological studies published between 1988 and 1993.  The given 
prevalence rates in the sample of diabetes patients
 
were at least three times greater than the 
prevalence rates of major depressive disorder found
 
in the general adult population (Gavard et 
al., 1993).  Expanding on this work, Anderson and colleagues published an additional meta-
analysis in 2001.  A total of 42 studies were used in this meta-analysis, with a combined sample 
size of 21,351 subjects.  The prevalence rate of depression across all studies using a diagnostic 
interview was estimated to be 11.4% in diabetes patients.  This differed significantly from a 
5.0% rate of depression in the "well" control group, again providing evidence that the prevalence 
of depression is higher in persons with diabetes (Anderson et al., 2001).    
 
Differences in type 1 vs. type 2 diabetes 
Since the disease process differs between type 1 and type 2 diabetes, it may be expected 
that psychological processes would also vary in the two populations (Barnard, Skinner, & 
Peveler, 2006).  Age of onset and duration of illness are generally quite different between type 1 
and type 2 diabetes patients.  While both sets of patients are likely to experience complications, 
persons with type 1 diabetes are more likely to experience acute symptoms of diabetes (e.g. 
ketoacidosis) while the onset of more general complications (e.g. neuropathy) are likely to occur 
sooner following diagnosis in type 2 patients.  Additionally, the treatment and self-care regimen 
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may be different for type 1 and type 2 diabetes (e.g. administration of exogenous insulin), 
creating different psychological burdens for each patient (Barnard et al., 2006).    
Evidence for disparities in prevalence rates of depression between type 1 and type 2 
diabetes is somewhat inconclusive.  The Anderson (2001) meta-analysis found that the overall 
risk of depression among patients with diabetes is almost two times that of the general 
population, noting that odds ratios did not differ significantly between type 1 and type 2 
diabetes.   
To estimate the prevalence rates in type 2 diabetes patients, Ali and colleagues (2006) 
conducted a meta-analysis of 51,331 subjects from ten controlled studies.  Studies with no 
control group, a small sample size or an unspecified type of diabetes were not included in the 
review.  After excluding one outlying study, Ali et al found that the overall prevalence of 
depression was 17.6% in patients with type 2 diabetes as compared to 9.8% in the control 
group.   Prevalence rates did not differ significantly as a result of assessment method or sampling 
procedures.  Additionally, odds ratios were calculated to show a significant increased risk of 
depression in persons with type 2 diabetes, though the odds ratios were somewhat lower than 
previously published figures (OR = 1.59, 95% CI 1.5-1.7) (Ali, Stone, Peters, Davies, & Khunti, 
2006; Anderson et al., 2001). 
 
Psychosocial correlates of depression in persons with diabetes  
  
The current literature yields a significant amount of research about the correlates of the 
comorbid condition.  Factors associated with depression among individuals with diabetes include 
female gender (Leonard E. Egede & Zheng, 2003; Katon et al., 2004; Nefs, Pouwer, Denollet, & 
Pop, 2012), lower socioeconomic status (Leonard E. Egede & Zheng, 2003; Everson, Maty, 
Lynch, & Kaplan, 2002), less education (Egede & Zheng, 2003; Katon et al., 2004), younger age 
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(Leonard E. Egede & Zheng, 2003; Katon et al., 2004; Peyrot & Rubin, 1999), being unmarried 
(Hanninen, Takala, & Keinanen-Kiukaanniemi, 1999; Katon et al., 2004), having a lack of 
perceived social support (Miyaoka, Miyaoka, Motomiya, Kitamura, & Asai, 1997), smoking 
status (Egede & Zheng, 2003; Katon et al., 2004), duration of diabetes (Talbot, Nouwen, 
Gingras, Belanger, & Audet, 1999), experiencing chronic stressors or negative life events (L. 
Fisher, Chesla, Mullan, Skaff, & Kanter, 2001), having multiple chronic conditions (Bell et al., 
2005), and having more diabetes complications (Katon et al., 2004; van Steenbergen-Weijenburg 
et al., 2011).  In type 2 diabetes patients, taking insulin has also been found to have an 
association with depression (Aikens, Perkins, Piette, & Lipton, 2008).  However, it should be 
noted that several of these correlates are not necessarily specific to diabetes patients.  Factors 
such as female gender, marital status, low socioeconomic status, smoking and lack of social 
support are also associated with depression in persons without diabetes (Adler et al., 1994; 
George et al., 1989; NIMH, 2011).   
 
Outcomes of the Comorbid Condition 
Depression in persons with diabetes is associated with adverse consequences, including 
poor glycemic control, poor adherence to self-care regimens, increased health care costs, and a 
higher risk of depression relapse (Ciechanowski et al., 2000; de Groot et al., 2001; Hanninen et 
al., 1999; Lin et al., 2004; Lustman et al., 2000; Papelbaum et al., 2011; X. Zhang et al., 
2005).  Additionally, depression has also been shown to have an impact on morbidity and 
mortality, such that depressed persons with diabetes have an increased risk of complications and 
higher mortality rates than their non-depressed counterparts (de Groot et al., 2001; Katon et al., 
2005; X. Zhang et al., 2005).  
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  Diabetes management requires diligent attention to several aspects of self-care, 
including eating a healthy diet, getting regular physical exercise, testing blood glucose levels and 
adhering to the prescribed medication regimen.  Regular physician visits are necessary to track 
the course of diabetes and monitor for incident complications.  Studies examining the impact of 
depression on self-care have shown that indeed depression does have a negative association with 
adherence (Ciechanowski et al., 2000; Ciechanowski, Katon, Russo, & Hirsch, 2003; Lin et al., 
2004).  Depression in diabetes patients has been associated with less physical activity, smoking, 
a poor diet and high rates of non-adherence to the medication regimen (Lin et al., 2004, 
Ciechanowski et al., 2000; Ciechanowski et al., 2003). 
Diabetes itself is associated with high medical costs.  However, diabetes and comorbid 
depression has been shown to increase both health care use and associated medical costs 
(Ciechanowski et al., 2000; Leonard E. Egede, Zheng, & Simpson, 2002).  Ciechanowski et al 
(2000) found that persons with diabetes were significantly more likely to have costs relating to 
primary care, emergency department, medical inpatient and mental health visits.  Consistent with 
these results, Egede et al (2002) found that diabetes patients with depression had more 
ambulatory care visits, filled more prescriptions, spent more on prescriptions (DiMatteo, Lepper, 
& Croghan, 2000; Leonard E. Egede et al., 2002) and had higher total health care expenditures 
than their non-depressed counterparts.  To highlight this disparity, their analyses demonstrated 
that health care expenditures for diabetes patients with depression were approximately $247 
million, while patients without depression spent approximately $55 million.  Thus, comorbid 
depression is associated with an almost five times greater increase in total health expenditures 
(Egede et al., 2002).     
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Depression has also been noted to have an association with complications from diabetes 
(e.g. diabetic retinopathy, nephropathy, neuropathy, macrovascular complications and sexual 
dysfunction). Results from a meta-analysis consistently showed a significant and positive 
direction of association between depressive symptoms and diabetes complications, such that an 
increase in depressive symptoms was associated with a significant increase in the number or 
severity of diabetes complications (de Groot et al., 2001; van Steenbergen-Weijenburg et al., 
2011).   
  Finally, the comorbidity between diabetes and depression has been associated with an 
increased risk of mortality.   Two studies in particular highlighted the impact of depression on 
mortality risk among persons with diabetes.  Results from the first study showed that after 
adjusting for age, sex, educational status and ethnicity, the risk of mortality in type 2 diabetes 
patients with major depression was 2.3 times that of the non-depressed diabetes group (Katon et 
al., 2005).  The second study, by Zhang et al., found that persons with diabetes meeting a cutoff 
score of 16 on the CES-D had a 54% greater mortality rate than their non-depressed 
counterparts.  That is, increased depressive symptom scores were associated with a higher risk of 
mortality in persons with self-reported diabetes in this sample (X. Zhang et al., 2005).   
As demonstrated, depression in diabetes patients has been associated with a number of 
adverse consequences, including an increased risk of morbidity and mortality.  The negative 
impact of the comorbid condition highlights the need for prevention, early detection and 
treatment.  A greater understanding of the causal mechanisms between diabetes and depression 
may help inform efforts to prevent the comorbid condition.      
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Causal Mechanisms 
There are several pathways in which depression and diabetes may be associated.   First, 
depression may develop as a result of psychosocial aspects of having diabetes, including the 
psychological demands of managing the disease, the daily burden of self-care behaviors and the 
long-term risk of serious complications (Talbot & Nouwen, 2000).  Second, underlying 
biochemical mechanisms may play a role in the association, such as a dysregulation of the 
hypothalamus-pituitary-adrenal (HPA) axis, hypercortisolemia, changes in hippocampal 
functioning, increased insulin resistance or inflammatory processes (Musselman, Betan, Larsen, 
& Phillips, 2003; Shelton & Miller, 2010).  While biological pathways may be an important area 
of research, this study will focus primarily on the psychological aspects of the disease.   
 
Psychosocial aspects of diabetes  
Depression in patients with diabetes may be conceptualized as a condition that results 
from the daily burden of having diabetes and diabetes complications (Talbot & Nouwen, 
2000).  Life with diabetes can be demanding, and lifestyle modifications may require a great deal 
of adjustment, even years after diagnosis.  Patients with diabetes must follow a self-care program 
that involves daily monitoring of blood glucose levels, adherence to more strict exercise and 
dietary guidelines, and a daily medication regimen (Snoek & Skinner, 2005).  This program of 
self-care is relentless with no hope of an ultimate "cure."  Patients who faithfully follow this 
daily regimen may still encounter frustrating fluctuations in their blood sugar readings, and 
complications from diabetes may occur regardless of their most diligent efforts.  A brief period 
of non-adherence can cause an acute crisis of hypo- or hyperglycemia, but extended periods of 
hyperglycemia can cause long-term physiological damage (e.g. blindness, amputations, 
neuropathy, kidney failure, early death).  A person with diabetes lives with not only the daily 
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hassles involved with their self-care regimen, but also the overhanging threat of frightening 
complications (Carney, 1998; Rubin & Peyrot, 2001; Snoek & Skinner, 2005).   
The emotional consequences of the disease can take a toll on diabetes patients.  As Rubin 
and Peyrot (2001) remark, persons with diabetes may "…feel frustrated, fed up, overwhelmed, or 
burned out.  Or they may report feeling chronically angry, guilty or fearful."  Fear, or the 
perceived threat of diabetes, significantly correlated with measures of depression in a 
community-based study (Connell, Davis, Gallant, & Sharpe, 1994).  Hopelessness, helplessness 
and guilt can also contribute to a depressive state, just as anxiety related to the disease can 
increase depressive symptoms (Carney, 1998).  Such depressive thoughts and feelings can 
impact behavior in the patient with diabetes, such that they may not follow their self-care 
regimen as closely (Lin et al., 2004), which in turn may impact blood glucose levels and 
heighten the feelings of depression and anxiety.  In essence, a "negative cascade" of thoughts, 
behaviors and actions can be triggered in the diabetes patient (Rubin & Peyrot, 2001), possibly 
leading to a full-blown depressive episode.   
The economic impact of diabetes may also play a role in the development or exacerbation 
of depression in persons with diabetes (Musselman et al., 2003). Diabetes is an expensive disease 
to treat. Direct costs to individuals with diabetes may include medical care, medications, and 
blood glucose testing supplies.  Other personal costs, such as increased insurance payments or 
loss of earnings, can accrue with the onset of diabetes.  Indeed, in a study of 75 Latino and 113 
white patients with type 2 diabetes, financial stress independently predicted depressive 
symptoms (L. Fisher et al., 2001).   
Some research suggests that it is not necessarily the objective burden of diabetes that 
increases the risk of developing depression.  Interestingly, in a population-based study of 1,586 
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men and women aged 50 years or older, patients with previously diagnosed type 2 diabetes had 
significantly higher BDI scores than individuals with diabetes that were formerly unaware of 
their condition, even after adjusting for age and other chronic conditions.  This finding suggests 
that depressive symptoms are related to the perceived burden of diabetes, in addition to actual 
health status (Palinkas, Barrett-Connor, & Wingard, 1991).  Depression has also been correlated 
with a greater perceived symptoms and symptom load in other studies (Ludman et al., 2004; 
Paschalides et al., 2004). 
A similar construct that may help explain the relationship between diabetes and 
depression is illness intrusiveness.  Illness intrusiveness is conceptualized as the degree to which 
activities and interests are affected by the illness itself.  Illness intrusiveness is hypothesized to 
increase depression as a result of the condition interfering with participation in with valued 
activities, and as an indirect reduction in perceived personal control (Devins, 2010).  In a study 
of illness intrusiveness, diabetes complications and depression, researchers found that illness 
intrusiveness was indeed related to higher depressive symptoms (Talbot et al., 1999), and an 
additional 2004 study found that depression was correlated a perceived lack of control 
(Paschalides et al., 2004). 
In sum, there is evidence to support the idea that psychosocial factors can play a role in 
the etiology of depression in persons with diabetes (Egede & Zheng, 2003; Talbot & Nouwen, 
2000).  Living with diabetes can be a significant life stressor, and having the disease can take its 
toll on the emotional and psychological well-being of any individual. Disease burden (real and 
perceived) and illness intrusiveness may all impact the development of depression in persons 
with diabetes.   However, research also indicates that coping styles may impact the relationship 
between stress and depressive symptoms (Aldao, Nolen-Hoeksema, & Schweizer, 2010; Billings 
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& Moos, 1981; C. J. Holahan, Moos, Holahan, Brennan, & Schutte, 2005)  In diabetes patients, 
coping has been hypothesized to be an intervening variable between perceptions of stressors and 
emotional and/or health outcomes (Duangdao & Roesch, 2008; Roesch & Weiner, 2001; Roesch, 
Weiner, & Vaughn, 2002).  A further examination of this relationship is warranted to understand 
the association of coping styles on depression in type 2 diabetes patients.   
 
Coping 
 
Models of coping 
Coping can be broadly described as an individual’s cognitive and/or behavioral attempts 
to tolerate and manage situations that are perceived as stressful (Duangdao & Roesch, 2008).  
Lazarus and Folkman (1984) were the first researchers to extensively study coping, defining it as 
‘constantly changing cognitive and behavioral efforts to manage specific external and/or internal 
demands that are appraised as taxing or exceeding the resources of the person’ (p. 141).  
 From this definition, Lazarus and Folkman (1984) derived two primary categories of 
coping: emotion-focused coping and problem-focused coping.  These categories described ways 
that individuals attempt to either change their emotional response to a stressor or change the 
source of stress directly.  Emotion-focused coping, or “regulating emotional responses to the 
problem,” involved the use of such coping strategies as: seeking emotional support, cognitive 
reappraisal, avoidance and minimization.  Conversely, problem-focused coping, or “coping that 
is aimed at managing or altering the problem,” involves the use of coping strategies such as 
making a plan of action (Lazarus & Folkman, 1984).  
In addition to the problem-focused and emotion-focused coping dichotomy, other higher-
order categories of coping were developed that examined the focus or orientation of the coping 
  
18 
 
strategy (Duangdao & Roesch, 2008; Skinner, Edge, Altman, & Sherwood, 2003).  For example: 
approach versus avoidance (Roth & Cohen, 1986), vigilance versus nonvigilance (Averill & 
Rosen, 1972); vigilance versus avoidance (Cohen & Lazarus, 1973; Janis & Mann, 1977); 
alloplastic versus autoplastic (Perrez & Reicherts, 1992); attention versus inattention  
(Kahneman, 1973); intrusion versus denial (Horowitz, 1976), and direct versus indirect (Barrett 
& Campos, 1991). Among many studies on coping, a commonly-used category to describe 
attention directed towards a threat was termed approach coping, while the category of avoidance 
coping was used to describe a deflection from a threat, or efforts to avoid the stressor altogether. 
(C. Holahan & Moos, 1987; Moos & Schaefer, 1993; Roth & Cohen, 1986).  Other researchers 
suggested that coping could be further defined in three categories: problem- or task-focused, 
emotion-focused, and avoidance coping (Endler & Parker, 1994).  All of these coping strategies 
were seen as voluntary methods of coping, such that the individual made conscious attempts to 
manage their emotions and behaviors in response to a perceived stressor.  
Newer models of coping expanded on prior models of voluntary coping and introduced 
the idea of involuntary (or automatic) reactions to stressors (Compas, Conner, Osowiecki, & 
Welch, 1997; Compas, Connor-Smith, Saltzman, Thomsen, & Wadsworth, 2001).  In Compas et 
al’s model (2001), both voluntary coping methods and involuntary responses to stress are 
described by engagement with or disengagement from the source of stress, and an individual’s 
emotional reaction to the stressor.  Engagement responses are those that are “oriented toward 
either the source of stress, or toward one’s emotions and thoughts,” while disengagement 
responses are “oriented away from the stressor and one’s emotions/thoughts” (Compas et al., 
2001).  Importantly, using the engagement versus disengagement descriptors, emotion-focused 
coping responses are not combined into one overarching category.   Emotion-focused responses 
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could fall under engagement (e.g. orienting to the emotion) or disengagement (e.g. orienting 
away from the emotion).   
In Compas et al’s proposed model of coping and stress responses, five overall factors are 
defined:  primary control engagement coping, secondary control engagement coping, 
disengagement coping, involuntary engagement, and involuntary disengagement. The five 
factors are further subdivided into voluntary coping and involuntary responses to stress.  
Voluntary coping responses are described by primary control engagement coping, secondary 
control engagement coping and disengagement coping, while involuntary responses to stress are 
divided into involuntary engagement and involuntary disengagement (Compas et al., 2006; 
Compas et al., 1997; Connor-Smith, Compas, Wadsworth, Thomsen, & Saltzman, 2000)..   
The first voluntary method of coping, primary control engagement coping, involves 
efforts to achieve control by directly changing the source of stress or one’s emotional responses 
to a stressor.  Primary control engagement coping encompasses responses such as problem 
solving (e.g. I try to think of different ways to deal with problems), emotional regulation (e.g. I 
do something to calm myself down), and emotional expression (e.g. I let my feelings out) 
(Compas et al., 2006; Compas et al., 1997; Connor-Smith et al., 2000).   
An additional method of voluntary coping, secondary control engagement coping, 
involves efforts to achieve control indirectly by adapting to the source of stress.  This method of 
coping consists of distraction (e.g. I think about happy things to take my mind off problems), 
cognitive restructuring (e.g. I think about the things I’m learning from the situation, or something 
good that will come from it), acceptance (e.g. I just go with the flow) and positive thinking (e.g. I 
tell myself that everything will be alright) (Compas et al., 2006; Compas et al., 1997; Connor-
Smith et al., 2000).  
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Finally, disengagement coping describes voluntary efforts to avoid or suppress the source 
of stress and emotional responses through relinquished control.   Disengagement coping 
encompasses coping strategies such as denial (e.g. I try to believe it never happened), avoidance 
(e.g. I try not to think about it), and wishful thinking (e.g. I wish things could be different). 
(Compas et al., 2006; Compas et al., 1997; Connor-Smith et al., 2000).   
The two involuntary responses to stress include involuntary engagement and involuntary 
disengagement.  Involuntary engagement coping consists of intrusive thoughts (e.g. thoughts 
about diabetes just pop in my head), rumination (e.g. I  can’t stop thinking about how I am 
feeling), physiological arousal (e.g. I get headaches), emotional arousal (e.g. I get upset by things 
that don’t usually bother me) and impulsive action (e.g. I can’t control my actions).  Involuntary 
disengagement responses involve emotional numbing (e.g. I don’t know what I feel), escape (e.g. 
I just have to get away), cognitive interference (e.g. my mind just goes blank) and inaction (e.g. I 
just lie around or sleep a lot) (Compas et al, 1997, Connor-Smith, Compas, Wadsworth, 
Thomsen & Saltzman, 2000, Compas et al, 2006). 
 
Measurement of Coping 
There are many common measures used to examine coping, including the Ways of 
Coping Scale (WOCS) (Folkman & Lazarus, 1988), the COPE and it’s condensed version, the 
Brief COPE  (Carver, 1997; Carver, Scheier, & Weintraub, 1989), the Coping Inventory for 
Stressful Situations (CISS) (Endler & Parker, 1990), and the Coping Strategies Inventory (Tobin, 
Holroyd, Reynolds, & Wigal, 1989).  Typically, coping instruments have been presented as self-
report questionnaires in a checklist format, though some measures (e.g. WOCS) may use 
interviewer-assisted probing or open-ended questions.  Instruments used to measure coping have 
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widely been acknowledged as having psychometric challenges, including problems with validity 
and reliability of coping scales, determining whether coping is a style or a process, delineating 
between the various dimensions of coping and being non-specific to the stressor being studied 
(Compas et al., 2001; De Ridder, 1997; Rexrode, Petersen, & O'Toole, 2008).  Additionally, 
coping researchers have often failed to distinguish between coping strategies and overarching 
categories of coping (De Ridder, 1997), or may have inadequately categorized coping strategies 
into higher-order categories.  For example, some higher-order categories of emotion-focused 
coping may encompass strategies such as cognitive restructuring and wishful thinking, despite 
the fact that use of these strategies may have very different outcomes and behavioral responses.   
The Responses to Stress Questionnaire (Connor-Smith et al., 2000) was designed in 
accordance with Compas et al’s five-factor model of coping and responses to stress.  The 
measure was specifically developed to circumvent many of the methodological issues with 
previous measures of coping (Compas et al., 2001).  On the RSQ, voluntary coping items were 
chosen to distinguish between adaptive strategies for emotional modulation and regulation in 
contrast to uncontrolled expression of emotions. Items reference a specific stressor being studied, 
such that different forms of the RSQ exist for different stressors (e.g. breast cancer vs. diabetes), 
though the basic content of the items remains the same across all RSQ versions. Additionally, 
respondents are asked to list particular coping strategies in an open-ended format, such that they 
are recalling actual behaviors and not simply checking off items on a checklist.  For example, on 
an item representing “problem solving,” respondent are asked to list problem-solving tactics used 
in response to a stressor.  (Compas et al., 2001; Connor-Smith et al., 2000).   
Coping, depression and diabetes  
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In prior studies of coping in samples of diabetes patients, problem-focused coping has 
been found to be associated with better metabolic control, emotional status, and better 
adjustment overall in patients with diabetes (Lundman & Norberg, 1993; Luyckx, Vanhalst, 
Seiffge-Krenke, & Weets, 2010; Samuel-Hodge, Watkins, Rowell, & Hooten, 2008).  Problem-
focused coping was negatively associated with anxiety and depression (Maes, Leventhal, & De 
Ridder, 1996; C. Zhang et al., 2009).  Problem-focused coping has also been associated with 
lower blood glucose levels, which is generally indicative of better diabetes-related outcomes 
(Luyckx et al., 2010; Smari & Valtysdottir, 1997; Sultan & Heurtier-Hartemann, 2001).  
When examining coping, depressive symptoms and diabetes-related outcomes, use of 
emotion-focused coping has demonstrated more equivocal results.  Some studies found emotion-
focused coping to be associated with poor adjustment and adherence to health regimens in 
chronically ill samples (Bombardier, D'Amico, & Jordan, 1990).  In other studies, patients with 
diabetes who engaged in emotion-focused coping experienced more distress, depression, and 
higher blood glucose levels (Duangdao & Roesch, 2008; Maes et al., 1996; Samuel-Hodge et al., 
2008).  Additionally, research showed that individuals with chronic illness who used more 
avoidance coping usually had poorer adjustment (Bombardier et al., 1990).   
However, other studies have found that the use of emotion-focused coping had positive 
outcomes, particularly when paired with problem-focused coping.  In a meta-analysis of diabetes 
and coping, Duangdao and Roesch (2008) found that emotion-focused coping was negatively 
associated with anxiety and depression, such that those engaged in emotion-focused coping 
experienced fewer symptoms of depression.  Researchers also noted that type 2 diabetes patients 
experienced better glycemic control when emotion-focused coping was used in tandem with 
problem-focused coping (Karlsen & Bru, 2002).   
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Methodological limitations may have skewed previous findings about coping and its 
association with depression and illness-related outcomes in persons with diabetes.  Again, 
common measures of emotion-focused coping may have grouped items that measured both 
adaptive and maladaptive coping strategies into one overarching subscale (Compas et al., 2006; 
Stanton et al., 2000).  For instance, venting may be associated with negative psychological 
outcomes (e.g. higher levels of anxiety and depression), while constructively expressing emotion 
may be associated with more positive outcomes.  Yet in prior studies, both styles of coping may 
have fallen under the category of “emotion-focused coping” (Stanton et al., 2000).   
Researchers noted that diabetes patients in particular may use coping strategies that are 
designed to reduce negative emotions associated with the disease and its daily maintenance 
(Duangdao & Roesch, 2008).  As such, it is particularly important to understand how these 
coping strategies affect both psychological and health outcomes in persons with diabetes.  The 
Response to Stress Questionnaire (RSQ) may help identify both helpful and problematic coping 
styles as they relate to emotion management (Connor-Smith et al., 2000).  Rather than broadly 
defining coping as “emotion-focused,” the RSQ attempts to identify voluntary methods of 
emotion-focused coping on different dimensions:  either primary engagement (e.g. I let someone 
know how I feel), secondary engagement (e.g. I distract myself) or disengagement (e.g. I try not 
to think about it).    
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The Current Study 
 
Overview 
The present study has several aims.  The main focus of the study is to examine the 
relationship of depressive symptoms and coping styles in a sample of type 2 diabetes patients 
using Compas and colleagues’ model of coping, specifically focusing on voluntary coping 
strategies.   Previous research has examined coping in diabetes patients with varied results, 
possibly as a result of imprecise coping measures.  This study will investigate how depressive 
symptoms are related to primary engagement coping, secondary engagement coping and 
disengagement coping styles.  As noted before, coping strategies may have an association with 
the development and maintenance of depressive symptoms.  As individuals may be able to 
consciously modify their voluntary coping styles, and psychological interventions may be 
designed to help facilitate this process, only voluntary coping is examined in relationship to 
depressive symptoms in this study.   
A secondary focus of the study is to examine the relationship between depressive 
symptoms, voluntary coping styles, diabetes self-care activities, glycemic control (HBA1c) and 
diabetes-related distress.  Previous studies have shown that depressive symptoms are associated 
with poorer health-related outcomes in diabetes patients, including poorer glycemic control, less 
adherence to the prescribed medical regimen (including diet and exercise), and higher diabetes-
related distress (Ciechanowski et al., 2000; de Groot et al., 2001; Hanninen et al., 1999; Lin et 
al., 2004; Lustman et al., 2000; X. Zhang et al., 2005).  The current study will attempt to 
replicate these findings.   
Additionally, specific methods of coping have been associated with diabetes-related 
outcomes.  For instance, avoidance coping has been found to be negatively associated with 
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poorer adjustment to the disease, while other methods of coping (e.g. approach or problem-
focused coping) have had associations with positive diabetes-related outcomes (Duangdao & 
Roesch, 2008).  This study will examine the relationship between coping and diabetes outcomes 
using Compas and colleagues’ model of coping.   
A final focus of the study is to validate the Responses to Stress Questionnaire in a sample 
of adult, type 2 diabetes patients.  The RSQ has previously been used in samples of adolescent 
type I diabetes patients (Jaser & White, 2011).  For the current study, the RSQ was modified for 
an adult population, and its stressor items were updated to reflect concerns that adult diabetes 
patients often encounter.  The Brief COPE, another widely-used measure of coping, will be 
included in the study to help validate the RSQ.   
 
Hypotheses 
 
Hypothesis I:  Relationship between depressive symptoms and voluntary coping in adult type 2 
diabetes patients.   
Primary control engagement coping.  Primary control engagement coping represents 
efforts to change or modify a stressor, and includes such strategies as problem solving and 
emotional regulation.  Previous studies have shown that “approach” strategies of coping, 
including problem-focused coping, have been negatively associated with depressive symptoms in 
diabetes patients.  As such, greater endorsement of primary control engagement coping strategies 
is expected to be associated with fewer depressive symptoms in this study. 
 Secondary control engagement coping.  Compas et al (2001) define secondary control 
engagement coping as efforts to adapt to a situation or stressor, and includes such strategies as 
positive thinking, cognitive restructuring, acceptance, and distraction.  In the current study, use 
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of secondary control engagement strategies should be associated with lower depressive symptom 
scores.   
Disengagement coping.  Disengagement coping is conceptualized as a coping strategy to 
avoid or distance oneself from a stressor (Compas et al., 1997).  Previous research with diabetes 
patients has shown an inverse association with avoidance coping and depressive symptoms, such 
that greater use of avoidance is related to greater levels of depression and emotional distress 
(Duangdao and Roesch, 2008).  Using the RSQ in studies of patients with breast cancer, 
disengagement coping and the involuntary coping response scales were associated with higher 
levels of emotional distress (Compas et al, 2006).  As such, it is expected that greater 
endorsement of disengagement coping will be associated with a higher number of depressive 
symptoms in this sample of type 2 diabetes patients.   
 
Hypothesis II: Depressive symptoms and diabetes-related outcomes.    
The results of many studies have shown that greater amounts of depressive symptoms are 
negatively correlated with diabetes-related outcomes (e.g. poorer glycemic control, lower 
adherence to self-care activities, higher diabetes-related distress) (de Groot et al., 2001, 
Ciechanowski et al., 2000; Hanninen, 1999; Lin et al., 2004; Lustman, Anderson et al., 2000, 
Zhang et al., 2005).  This study seeks to replicate these findings, such that higher depressive 
symptoms would be expected to correlate with poorer diabetes-related outcomes in this sample 
of type 2 diabetes patients.   
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Hypothesis III:  Voluntary coping and diabetes-related outcomes.   
Research has shown that, in addition to better psychological outcomes, problem-focused 
or approach-related coping has been associated with positive health-related outcomes.  This 
study, using Compas et al’s model of coping, will examine how coping relates to measures of 
diabetes-specific outcomes, including metabolic control (e.g. HbA1c levels) and adherence to 
self-care activities and medical recommendations.  Primary and secondary control engagement 
coping are expected to be associated with better diabetes-related outcomes, while disengagement 
coping may be associated with poorer diabetes-related outcomes.   
 
Hypothesis IV:  Validation of the RSQ in a sample of type 2 adult diabetes patients.   
The RSQ has been used with samples of adolescents with type 1 diabetes (Jaser & White, 
2011) and adult women with breast cancer (Compas et al., 2006).  However, the RSQ has not 
been validated for use with adults with diabetes.  The current study will attempt to validate the 
RSQ’s five-factors (e.g. primary control engagement coping, secondary control engagement 
coping, disengagement coping, involuntary engagement coping, involuntary disengagement 
coping) through confirmatory factor analysis.  Convergent and discriminant validity will also be 
examined through correlations with the Brief COPE.    
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CHAPTER II 
 
METHODS 
 
Participants  
 
The study included 116 adults with type 2 diabetes recruited from Vanderbilt University 
medical clinics. Participants were between the ages of 18 and 80 (M = 50.0 years, SD = 10.4), 
were able to speak and read English and received their diabetes care at a Vanderbilt University 
clinic. Participants must also have been diagnosed with type 2 diabetes for at least six months, 
such that depressive symptoms would not reflect initial adjustment to the diabetes diagnosis.  
The sample included 37 male and 79 female participants (32% and 68% respectively).  The 
majority of the patients were Caucasian (78.4%), with the remainder African-American (18.1%), 
Asian (2.6%) or Other (0.9 %).   
 
Measures 
 
Depressive Symptoms 
The Center for Epidemiologic Studies Depression Scale (CES-D) was used as a measure 
of depressive symptoms.  The CES-D, developed at the Center for Epidemiologic Studies of the 
National Institutes of Mental Health (Radloff, 1977), is a 20-item self-report measure used to 
estimate depressive symptom prevalence within the last week.  In addition to adults in the 
general population, the CES-D has been widely used in studies with diabetes patients (Carnethon 
et al., 2007; Osborn et al., 2010; Pouwer et al., 2010). 
Responses to the CES-D are based on the frequency of symptom occurrence during the 
past seven days.  Participants rated depressive symptoms (e.g. “I felt depressed,” “My sleep was 
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restless”) using a 4-point ordinal scale: Rarely or none of the time (less than 1 day); some or a 
little of the time (1-2 days); occasionally or a moderate amount of the time (3-4 days); most or all 
of the time (5-7 days).  Four of the items (e.g. “I felt that I was just as good as other people,” I 
felt hopeful about the future,” “I was happy,” “I enjoyed life”) were reverse-coded.  Scores of all 
items are summed to create a total CES-D score.  Higher scores on the CES-D indicate greater 
symptomatology.  A total cutoff score of 16 indicates “significant” or “mild” depressive 
symptomatology, as it is equivalent to experiencing six symptoms for most of the previous week 
or a majority of symptoms on one or two days.  The CES-D has demonstrated good internal 
consistency in previous studies (Carnethon et al., 2007; Osborn et al., 2010; Pouwer et al., 2010).  
Internal consistency for the current sample was α=.95. 
 
Methods of coping 
Participants’ methods of coping were measured with two instruments:  The Responses to 
Stress Questionnaire (RSQ) and the Brief COPE.  The RSQ assessed participants’ coping 
strategies directly in response to diabetes-related stressors.  The RSQ has previously been used in 
samples of adolescent type I diabetes patients (Jaser & White, 2011) and adult breast cancer 
patients (Compas et al., 2006).  For the current study, the RSQ was modified for an adult 
population with diabetes.  Accordingly, items on the RSQ were designed to reflect concerns that 
adult patients often have with their diabetes.  The first 10 questions were specifically tailored to 
the concerns of adults with type 2 diabetes (e.g. worries about long-term complications of 
diabetes, feelings of guilt).  Participants were asked to rate how stressful these problems were 
and how much perceived control they had over these problems, measured on a 4-point Likert 
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scale (0 =not at all, 1 =a little, 2 =some and 3 =a lot). The following 57 items assessed the 
participants’ responses to the stressors identified in the first 10 questions.  
The RSQ is designed to provide data on all responses to stress, but the current analyses 
focus mainly on three voluntary coping factors: primary control engagement coping (e.g. 
emotional expression, problem solving), secondary control engagement coping (e.g. positive 
thinking, acceptance, cognitive restructuring) and disengagement coping (e.g. avoidance, wishful 
thinking, denial).   The RSQ has 9 items addressing primary control engagement coping, 12 
items on secondary control engagement coping and nine items on disengagement coping.  
Previous studies have demonstrated that the RSQ has good reliability, validity and internal 
consistency (Connor-Smith et al. 2000; Compas et al. 2006, Jaser et al., 2011).  In this study, 
internal consistency was as follows: α=.78 for primary control coping, α=.81 for secondary 
control coping, α=.79 for disengagement coping. 
As the RSQ has not yet been validated in a sample of adult diabetes patients, an 
additional measure of coping, the Brief COPE, was included in the study.  The Brief COPE is a 
multidimensional coping inventory designed to assess a broad range of coping strategies and 
responses to psychological stress (Carver, 1997).  This measure is a shortened version of the 
original COPE inventory (Carver et al., 1989).  The Brief COPE has 28 items, with two items in 
each of the 14 subscales.  The 14 subscales include:  self-distraction, active coping, denial, 
substance use, emotional support, instrumental support, behavioral disengagement, venting, 
positive reframing, planning, humor, acceptance, religion and self-blame.  Participants rated their 
use of coping mechanisms on a four-point Likert scale ranging from “not at all” (1) to “a great 
deal” (4).  High scores indicate a greater use of any particular coping strategy.   
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The Brief Cope showed marginal to adequate internal consistency among community 
samples (Carver, 1997) and samples with diabetes patients (Yi-Frazier et al., 2010), with 
reliability coefficients for the subscales ranging from .50 to .93.  Estimates for the test-retest 
reliability of the COPE inventory ranged from .42 to .89 (Carver et al., 1989).  In the current 
study, Chronbach’s alphas for the subscales were as follows:  self-distraction, α=.60; active 
coping, α=.71; denial, α=.74; substance use, α=.89; emotional support, α=.83; instrumental 
support, α=.86; behavioral disengagement, α=.56; venting, α=.57; positive reframing, α=.77; 
planning, α=.72; humor, α=.67; acceptance, α=.57; religion, α=.93; self-blame, α=.79.   
 
Diabetes Self-Management 
Diabetes self-management behaviors were measured using the Summary of Diabetes 
Self-Care Activities (SDSCA).  The SDSCA assesses self-care behaviors such as general diet, 
specific diet, blood-glucose testing, foot care, exercise and smoking.   Participants are asked to 
rate how many days out of the past week they engaged in self-care behaviors (e.g. “How many of 
the last seven days have you followed a healthy eating plan?”).  Scores ranged from 0 (no days) 
to 7 (every day).  Several items (high-fat diet, smoking) were reverse coded.  A total self-care 
score was calculated for this study to obtain a global view of self-care behavior.  Total scores in 
the study ranged from 6-63.  Higher total scores indicate a higher degree of compliance with 
self-care recommendations.  Prior studies found the SDSCA to have adequate internal 
consistency and fair test-retest reliability (Toobert, Hampson, & Glasgow, 2000).  The internal 
consistency for the current sample was α=.74.  
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Diabetes-Related Distress 
Diabetes-related distress was measured using the revised Problem Areas in Diabetes 
(PAID-2), an expanded version of the original scale (Polonsky, 2000; Polonsky et al., 1995).   
The PAID-2 consists of 28 items that cover a range of emotional problems frequently reported in 
type 2 diabetes (e.g. “feeling that diabetes controls my life,” “feeling that I have to hide my 
diabetes from others”). Each item is scored on a 6-point Likert scale (0="Not a problem," 
3=”Moderate Problem,” 6="Serious Problem"). A total scale score is calculated by summing the 
item responses.  Total scale scores range from 0 – 168, with higher scores indicating greater 
amounts of diabetes-related distress and a lower diabetes-specific quality of life.  The earlier 
version of the PAID demonstrated consistently high internal reliability (α= 0.90) and good test–
retest reliability (Polonsky et al., 1995; Welch, Jacobson, & Polonsky, 1997; Welch, Weinger, 
Anderson, & Polonsky, 2003)  Subsequent studies using the PAID-2 found internal consistencies 
of α= .93 (Glasgow et al., 2004).  Internal consistency for the current sample using the PAID-2 
was α=.95.  
 
Metabolic control and diabetes complications 
Glycosylated hemoglobin (HbA1c) was obtained from participants' medical records as a 
measure of metabolic control.  HbA1c is an average measure of diabetes control over a period of 
8–12 weeks.  An HbA1c of <7% is considered to be the ideal level of diabetes control for adults 
with type 2 diabetes, with a normal range of HbA1c being between 4–5.9% (ADA, 2009). 
HbA1c analyses were performed at Vanderbilt clinics from a fingerstick blood sample.  The 
presence of diabetes complications (e.g. retinopathy, neuropathy) were also obtained from 
participants’ medical records.  
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Demographic Information 
Participants also completed a Demographic Form designed for this study to collect 
demographic information about participants.  Questions included information about age, gender, 
race/ethnicity, marital status, household income, current employment, height, weight, duration of 
diabetes, presence of diabetes complications, diabetes medications, and mental health treatment 
(see Appendix C). 
 
Procedure 
 
Following the protocol approved by the Vanderbilt University Institutional Review 
Board, eligible participants were recruited from Vanderbilt University medical clinics and 
through the Vanderbilt University VICTR research email distribution list.  The VICTR Research 
Notification Distribution List is a recruitment tool, available to Vanderbilt and Meharry 
researchers, that reaches over 18,500 Vanderbilt faculty/staff and members of the Middle 
Tennessee community.  The recruitment email (see Appendix A) was distributed on three 
different dates (7/28/10, 4/18/11 and 10/28/11) and yielded approximately 95 unique responses.  
Additional participants were recruited using flyers distributed by nurse practitioners at the 
Eskind Diabetes Clinic at Vanderbilt University (see Appendix B).   
Though a paper measure was offered, 100% of participants completed an online 
questionnaire.  The questionnaire was constructed and hosted using REDCap Survey (Research 
Electronic Data Capture), Vanderbilt University’s proprietary data collection software tool.  
After a brief eligibility screener (i.e. answering “yes” to being 18 or older, having been 
diagnosed with type 2 diabetes for over six months, and receiving medical care at a Vanderbilt 
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clinic), the participant electronically endorsed an informed consent document.  The survey 
measures were then presented in the following order:  Demographic Information, CES-D, Brief 
Cope, SDSCA, RSQ, PAID.  Survey respondents were compensated for their time: all 
participants received a $10 Target gift certificate after completion of the questionnaire.  The 
participants chose to receive the gift certificate either electronically or by regular mail.   
 
Data Analysis  
Most data were analyzed with descriptive and inferential statistics using Statistical 
Package for the Social Sciences (SPSS) for Windows Release 19.0. Statistical methods included 
frequency, percentage, mean, standard deviations, bivariate correlations, and hierarchical 
multiple regression. Confirmatory factor analyses were conducted using Mplus, version 6.0. 
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CHAPTER III 
 
RESULTS 
 
Overview of Hypotheses to be Tested 
 
The proposed study has several aims:  1) to examine the relationship between depressive 
symptoms and coping in a sample of type 2 diabetes patients; 2) to examine the relationship 
between coping, depressive symptoms and diabetes-related outcomes, including self-care 
behaviors, diabetes-related distress and metabolic control; and 3) to validate the RSQ in a sample 
of adult type 2 diabetes patients.   
In regards to depressive symptoms and coping, it is expected that greater use of primary 
control engagement coping and secondary control engagement coping will be associated with 
lower total depressive symptoms, while disengagement coping and involuntary coping efforts 
will be associated with higher total depressive symptoms.  Furthermore, it is expected that higher 
depressive symptom scores will be related to higher diabetes-related distress, higher HbA1c 
values and lower frequencies of diabetes self-care behaviors.  Greater use of voluntary 
engagement styles of coping (primary and secondary) may be related to better diabetes-related 
outcomes (e.g. lower diabetes-related distress, lower HbA1c values, higher frequencies of self-
care behaviors) while disengagement coping is expected to be negatively correlated with these 
variables.   
Finally, the RSQ is expected to follow the five-factor model of coping and stress in this 
sample of diabetes patients:  confirmatory factor analyses are expected to show a three-factor 
model of coping (primary control engagement, secondary control engagement, and 
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disengagement) and a two-factor model of involuntary stress responses (involuntary engagement 
and involuntary disengagement).  Additionally, correlations with the Brief COPE are expected to 
show both convergent and discriminant validity.   
  
Data Analyses 
 
Demographic data. Descriptive statistics including frequencies, percentages, means, and 
standard deviations were performed and reported on the following demographic variables: age, 
gender, ethnic background, household income, marital status, educational level, employment 
status, duration of diabetes, HbA1c levels, diabetes complications and diabetes medications.  
Research hypotheses.  Descriptive statistics including frequencies, percentages, means, 
and standard deviations were performed and reported on depression scores, diabetes-related 
distress, coping strategies and self-care activities. Descriptive statistics including means and 
standard deviations were performed and reported to describe the self-care behavior and A1c 
levels of individuals with type 2 diabetes. Bivariate correlations were conducted to determine if 
there were significant relationships between coping strategies, depression scores, diabetes-related 
distress, HbA1c levels, and self-care activities. Hierarchical multiple regression was conducted 
to determine which independent variables (diabetes complications, HbA1c values, coping 
strategies) predicted depression scores after controlling for demographic variables (age, gender, 
SES).  The convergent and discriminant validity of the RSQ was examined through bivariate 
correlations between the RSQ and the Brief COPE.  Finally, confirmatory factor analyses were 
performed to test the hypothesized model of voluntary and involuntary responses to stress in this 
sample of type 2 diabetes patients.   
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Participant Characteristics 
 
Table 1 summarizes the frequency distributions for age, gender, race/ethnicity, marital 
status, household income, educational level, and employment status.  A larger proportion of the 
participants were female (68.1%) while males accounted for 31.9% of the sample. Participants 
ranged in age from 23 to 73 years with a mean age of 50 years (SD = 10.4). Most of the 
participants were Caucasian (78.4%), with the remainder African-American (18.1%), Asian 
(2.6%) or Other (0.9 %).  The majority of the participants were married or living with a partner 
(64.7%).  
This particular sample appeared to be well-educated:  over one-third of the participants 
(37.0%) reported attending some college or technical school, and 56.9% reported either a college 
or graduate education level. The large majority of the participants (87.1%) were currently 
employed. Annual incomes ranged from less than $25,000 to over $100,000 per year. Almost a 
third of the sample (38.7%) had household incomes of less than $50,000, while 61.3% of the 
participants had incomes of $50,000 or more. 
 
 
Descriptive Statistics for Study Variables 
 
Diabetes and metabolic control. Disease characteristics of the sample are presented in 
Table 2.  The duration of diabetes ranged from six months to over 10 years. Approximately three 
quarters of the participants (75.9%) reported having type 2 diabetes for ten years or less.  HbA1c 
levels were between 5.7% and 14.0%, with a mean of 7.5% (SD = 1.5), indicating on average 
that participants’ blood sugar levels were not in good control: in healthy persons, the reference 
range of HbA1c  is between 4%–5.9%, and diabetes patients are advised to keep their HbA1c 
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levels below 7.0% (ADA, 2009).  Many participants had one or more diabetes complications (M 
= 2.3, SD = 1.6), with many reporting hypertension (66.7%) or hyperlipidemia (63.2%).  Over 
half the sample was taking oral medications alone (59.8%) while approximately one-third 
(34.2%) of the participants were taking insulin or a combination of insulin and oral medications.   
 
Table 1.  Participant Characteristics  
Variable Range Mean ± SD or N 
(%) Age 18-80 50.0 ± 10.4 
Gender Female 79 (68.1%) 
 Male 37 (31.9%) 
Race/ethnicity Caucasian 91 (78.4%) 
 African-American 21 (18.1%) 
 Asian 3 (2.6%) 
 Other 1 (0.9%) 
Marital Status Single 14 (12.1%) 
 Living with partner 8 (6.1%) 
 Married 67 (57.8%) 
 Separated 1 (0.9%) 
 Divorced 22 (19.0%) 
 Widowed 4 (3.4%) 
Educational level Some high school 1 (0.9%) 
 Graduated high school 6 (5.2%) 
 Some college 28 (24.1%) 
 Technical school/associate’s 15 (12.9%) 
 Graduated college 38 (32.8%) 
 Post-graduate degree 28 (24.1%) 
Household income < $25,000 per year 10 (9.0%) 
 $25,000 -$50,000  33 (29.7%) 
 $50,000 - $75,000 32 (28.8%) 
 $75,000-$100,000 22 (19.8%) 
 >$100,000 per year  14 (12.6%) 
Current employment Employed 101 (87.1%) 
 Not employed 15 (12.9%) 
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Table 2.  Disease Characteristics of Sample. 
Variable Range Mean ± SD or  N (%) 
Duration of diabetes 6 months – 1 year 6 (5.2%) 
 1 year – 5 years 44 (37.9%) 
 5 years – 10 years 38 (32.8%) 
 Over 10 years 28 (24.1%) 
HbA1c 5.7 – 14.0 7.5 ± 1.5 
Diabetes complications Total number (mean) 2.3 ± 1.6 
 Heart disease 18 (15.4%) 
 Kidney disease 20 (17.2%) 
 Retinopathy  14 (12.1%) 
 Hypertension 78 (66.7%) 
 Hyperlipidemia 74 (63.2%) 
 PVD 6 (5.2%) 
 Neuropathy 29 (24.8%) 
 Gum disease 8 (6.9%) 
 Foot problems 16 (13.8%) 
 Erectile dysfunction 7 (6.0%) 
 Other 2 (1.7%) 
Type of medication Oral medications 70 (59.8%) 
 Insulin 15 (12.8%) 
 Both oral med and insulin 25 (21.4%) 
 None 5 (4.3%) 
 
Depressive symptoms, diabetes-related distress, and self-care activities. Table 3 shows 
the means and standard deviations for the CES-D, the PAID, and the SDSCA, including diet, 
exercise, blood glucose testing, foot care, medication, and total self-care behavior.  The CES-D 
measured past-week depressive symptoms, with a cutoff score of 16 generally being 
acknowledged as a threshold for mild depression.  The mean CES-D score for this sample was 
11.5 (SD = 10.9), with a range of scores between 0 and 45.  Approximately 54.5% of the sample 
scored 16 or higher on the CES-D, indicating a relatively large percentage of the sample was 
experiencing symptoms of at least mild depression in the past week.   
Total scores on the PAID-2 can range from 28 (no problems with diabetes) to 168 
(serious problems with diabetes).  Higher scores on the PAID denote greater overall diabetes-
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related distress.  In this sample, scores fell between 28–165 with a mean of 64.1 (SD = 27.2).  Of 
the PAID subscales, participants were the most likely to endorse regimen-related distress (e.g. 
“feeling like I am failing with my diabetes regimen”), and the least likely to endorse physician-
related distress (e.g. “feeling that my doctor doesn’t give me clear enough directions on how to 
manage my diabetes”).   
On the SDSCA, total self-care behavior scores ranged from 6 to 63 with a possible score 
range from 0-63. Mean self-care behavior score was 32.8 (SD = 12.8) indicating a moderate 
participation level in self-care activities.  Participants reported the most days for self-care 
behavior in the area of diet (M = 4.1, SD = 1.5) and the least number of days of self-care 
behavior in the area of exercise (M = 2.9, SD = 2.5). Only ten participants acknowledged 
smoking.  
Table 3.  Ranges, Means and Standard Deviations for the CES-D, PAID and SCSCA. 
Variable Range Mean (SD) 
CES-D 0-60 11.5 (10.9) 
PAID   
     Total 28-168 64.1 (27.2) 
          Emotional distress 7-42 18.8 (9.2) 
          Interpersonal distress 7-42 13.4 (7.8) 
          Regimen-related distress 7-42 21.9 (9.8) 
          Physician-related distress 7-42 10.5 (6.2) 
SDSCA   
     Total self-care behavior 0-63 32.8 (12.8) 
          Diet 0-7 4.1 (1.5) 
          Exercise 0-7 2.9 (2.5) 
          Foot care 0-7 3.1 (2.5) 
          Blood glucose testing 
 
0-7 3.6 (2.7) 
 
Coping.  Coping was measured with the diabetes version of the Responses to Stress 
Questionnaire (RSQ) and the Brief COPE.  Based on prior studies using the RSQ, both raw 
scores and proportion scores were generated for this measure (Compas et al., 2006).  Raw scores 
for the RSQ were generated by summing the scores on the specific items within each 3-item 
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parcel or factor and dividing by the number of items to obtain the mean score per item.  Missing 
data were estimated by using mean responses for completed items in the same parcel.  Proportion 
scores were calculated by dividing each parcel or factor by the sum of all the items on the RSQ.  
This method of scoring negates potential response bias by providing an index of the relative 
amount of each coping style used (Connor-Smith et al., 2000; Osowiecki & Compas, 1998).  
Raw RSQ scores were used for reliability analyses and factor analyses, while both raw and 
proportion scores were used in the analyses of correlations with other measures (Compas et al., 
2006).  Means and standard deviations for RSQ raw and proportion scores are presented in Table 
4.   
 
Table 4.  Means and Standard Deviations for the RSQ (Raw and Proportion Scores). 
Variable Mean (SD) 
Primary control engagement   
     Raw score 2.29 (0.60) 
     Proportion score 0.22 (0.11) 
Secondary control engagement   
     Raw score 2.62 (0.57) 
     Proportion score 0.37 (0.13) 
Disengagement  
     Raw score 2.03 (0.59) 
     Proportion score 0.14 (0.07) 
Involuntary engagement   
     Raw score 1.71 (0.57) 
     Proportion score 0.17 (0.10) 
Involuntary disengagement  
     Raw score 1.50 (0.52) 
     Proportion score 0.09 (0.08) 
Mean raw scores reflect the mean score per item on a 1-4 scale.   
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The Brief COPE was used primarily to validate the Responses to Stress Questionnaire.  
The scale has 14 subscales, each comprised of two items, and scores can range from 2-8 on each 
subscale. Higher scores indicate that the specific type of coping (e.g. self-distraction) is used 
more frequently.  In this sample, participants endorsed using acceptance (M= 6.3, SD=1.7), 
planning (M=5.3, SD=1.8) and active coping (M=5.3, SD=1.8) the most frequently. Means and 
standard deviations for the Brief COPE are presented in Table 5.   
 
Table 5.  Means and Standard Deviations for the Brief COPE. 
Variable  Mean (SD) 
Self-distraction  4.1 (1.8) 
Active coping  5.3 (1.8) 
Denial  2.4 (1.1) 
Substance use  2.1 (0.6) 
Emotional support  4.4 (2.0) 
Instrumental support  4.0 (1.8) 
Behavioral disengagement  2.6 (1.0) 
Venting  3.2 (1.3) 
Positive reframing  4.9 (2.0) 
Planning  5.3 (1.8) 
Humor  3.2 (1.5) 
Acceptance  6.3 (1.7) 
Religion  4.9 (2.3) 
Self-blame  3.7 (1.7) 
 
Gender differences.  Significant gender differences have been noted in previous studies 
of depression (Nolen-Hoeksema, 1987), coping (Connor-Smith et al., 2000), coping with 
diabetes (Smari & Valtysdottir, 1997), diabetes-related distress (Sultan & Heurtier-Hartemann, 
2001) and metabolic control (Smari & Valtysdottir, 1997; Sultan & Heurtier-Hartemann, 2001).  
As such, independent samples t-tests were performed to examine possible gender differences in 
the current study.  No significant differences were observed on demographic variables (e.g. age, 
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household income), depressive symptoms (e.g. overall CES-D score), self-care behavior or 
metabolic control.  Results trended towards significance on scores of diabetes-related distress (t 
= -1.86, p < .07), with women generally scoring higher than men on total PAID scores.  In 
regards to coping, men and women differed only on raw scores of primary control engagement 
coping (t = -2.28, p < .05), with women reporting higher scores than men.  However, this 
difference was not found when examining RSQ proportion scores.   
 
Hypotheses Testing 
 
Relationship between depressive symptoms and voluntary coping in diabetes patients.   
To examine the relationship between depressive symptoms and coping, hierarchical 
multiple regressions were performed.  The analysis examined which independent variables 
(number of diabetes complications, duration of diabetes, use of insulin, primary control 
engagement coping, secondary control engagement coping and disengagement coping) predicted 
CES-D scores after controlling for age, gender, income and education.  Results from the 
correlation and regression analyses for associations between independent variables and the CES-
D are presented in Table 9.  Independent variables were entered hierarchically in sections:  
model 1 (control variables), model 2 (control and clinical variables), and model 3 (control, 
clinical and coping variables).   
When entering the control variables, age and income yielded statistically significant 
negative associations with the CES-D in models 1 and 2; however, these associations were 
attenuated when coping variables were entered into the regression equation.  Model 1 accounted 
for 13% of the variance (R
2
=.13, F(4,104)=3.88, p<.01).  When clinical variables (e.g. total 
number of complications, time since diagnosis, treatment with insulin) were added, only 
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treatment with insulin yielded a significant association, but that association was also attenuated 
in the final model.  Clinical variables accounted for an additional 5.1% of the variance (R
2
=.18, 
F(7,101)=3.19, p<.01) of depression scores.  Entering the coping variables (primary control 
engagement coping, secondary control engagement coping, disengagement) in the third model 
led to a statistically significant increase of 24.0% in variance accounted for in depression scores 
(R
2
=.13, F(10,98)=7.13, p<.01).  The final model, including all independent variables, accounted 
for a total of 42.1% of the variance in CES-D scores.   
All three coping variables yielded statistically significant bivariate correlations with 
scores on the CES-D, reflecting that primary and secondary control coping were associated with 
lower depressive symptoms and disengagement coping was associated with higher depressive 
symptoms.  The same tendency was found for these variables in the regression equation, with the 
exception of the non-significant association found between disengagement coping and depressive 
symptom scores.  Upon review of the β weights, secondary control engagement coping (β = -.44, 
t = -4.58, p<.01) accounted for the highest amount of the variance in CES-D scores, followed by 
primary control engagement coping (β = -.34, t = -3.53, p<.01).   Greater values of both primary 
and secondary control engagement coping predicted lower overall CES-D scores.   
 
Depressive symptoms and diabetes-related outcomes 
The second set of hypotheses examines the relationship between depressive symptoms 
and diabetes-related outcomes, including metabolic control (HbA1c), diabetes-related distress, 
and self-care behaviors.  Based on a review of the existing literature, total depressive symptom 
scores were expected to be positively correlated with diabetes-related distress and negatively 
correlated with self-care behaviors.  Prior research on the relationship between depressive 
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symptoms and HbA1c has been mixed, but in this study, higher depressive symptom scores were 
expected to be correlated with larger HbA1c values.  Correlations between the CES-D, the 
PAID-2, the SDSCA and HbA1c are presented in Table 7.   
 
Table 6.  Results From Correlation (Pearson’s r) and Regression Analysis for Associations 
Between Independent Variables and the CES-D.   
  
r 
Model 1 
β 
Model 2 
β 
Model 3 
β 
Control Variables 
    
     Age -.17   -.24
** 
-.20
*
  .01 
     Gender  .02 -.10 -.11 -.04 
     Income    -.25**   -.36**   -.36
**
 -.15 
     Education  .01 .13 .15 .15 
Clinical indicators     
     Complications .01  -.07 -.11 
     Disease duration .14  .01  .03 
     Insulin   .22*  .24
*
 .14 
Coping Variables     
     Primary Control    -.46**     -.34
**
 
     Secondary Control   -.51**     -.44
**
 
     Disengagement    .27**   -.11 
R
2  
 .13** .18
**
    .42
**
 
R
2
 change 
 
 .05
**
     .24** 
*p < .05,  **p < .01 
First, the relationship between depressive symptoms and diabetes-related distress was 
investigated.  A significant and positive correlation was found between the CES-D and the 
PAID-2, including total scores and all subscales on the PAID-2.  The highest correlations were 
found between the CES-D and the PAID “emotional distress” subscale (r = 0.52, p < .01) and 
total PAID-2 scores (r = 0.51, p < .01).  Thus, higher numbers of depressive symptoms were 
associated with higher diabetes-related distress, particularly in regards to emotions surrounding 
the disease (e.g. feeling “worried” or “burned out” by having diabetes).   
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Associations between depressive symptoms and diabetes self-care behaviors were also 
examined.  Significant but somewhat weak negative associations were found between the CES-D 
and dietary self-care behaviors (r = -0.25, p < .01) and the overall SDSCA score (r = -0.22, p < 
.01). As such, diabetes patients with higher depressive scores were less likely to report following 
dietary guidelines. Correlations between depressive symptoms and self-reported blood sugar 
testing, foot care and exercise were also in the negative direction, but they were not statistically 
significant.  Finally, the relationship between depressive symptom scores and metabolic control 
(as measured by HbA1c) was investigated.  Contrary to predictions, there was no association 
between the CES-D and HbA1c in this study (r = 0.10, p > .05).     
 
Coping and diabetes-related outcomes 
The third set of hypotheses examines the relationship between voluntary coping (e.g. 
primary control, secondary control and disengagement coping) and diabetes-related outcomes, 
including diabetes-related distress, self-care behaviors and metabolic control (HbA1c).  Primary 
control engagement coping and secondary control engagement coping were expected to be 
negatively correlated with diabetes-related distress, positively correlated with self-care 
behaviors, and negatively correlated with HbA1c.  Disengagement coping, on the other hand, 
was expected to be positively correlated with diabetes-related distress, negatively correlated with 
self-care behaviors, and positively correlated with HbA1c.  Correlations between primary control 
engagement coping, secondary control engagement coping, disengagement coping, the PAID-2, 
the SDSCA and HbA1c are presented in Table 7.   
First, the relationship between coping variables and diabetes-related distress was 
investigated.  Significant negative correlations were found between positive control engagement 
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coping and the PAID-2, including all subscales and total scores PAID-2.  The associations would 
be considered moderate to strong negative correlations, as r’s ranged from -.32 to -.47 (p < .01). 
Similarly, significant negative correlations were found between secondary control engagement 
coping and the PAID-2, again including all subscales and total scores PAID-2.  These negative 
associations were stronger than primary control engagement coping, as r’s ranged from -.55 to -
.71 (p < .01).  Thus, higher amounts of both primary and secondary control coping were 
associated with lower diabetes-related distress.  Secondary control engagement coping in 
particularly was highly negatively correlated with the emotional distress subscale of the PAID-2 
and overall PAID scores.  Also in line with predictions, disengagement coping was positively 
associated with the PAID-2 (r’s ranging from .21 to .53, p < .05), demonstrating that higher 
levels of disengagement coping are related to higher levels of diabetes-related distress.   
Associations between coping and diabetes self-care behaviors were also examined.  
Significant but moderate positive associations were found between primary control engagement 
coping and most diabetes self-care behaviors, with r’s ranging from .23 to .39 (p < .01).  
However, the correlation between primary control engagement coping and self-reported blood 
sugar testing was not significant.  Associations between secondary control engagement coping 
and self-care behavior were less robust, as significant positive correlations were found only with 
total self-care scores (r = 0.24, p < .05) and subscales relating to diet (r = 0.30, p < .01) and 
exercise (r = 0.19, p < .05).  Disengagement coping was negatively correlated with all diabetes 
self-care behaviors (r’s ranging from .19 to .49, p < .05), with the strongest associations again 
relating to dietary self-care behaviors.  Thus, patients who used greater disengagement coping 
were less likely to report following recommended self-care behaviors.   
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Finally, the association between coping variables and metabolic control were examined.  
Contrary to predictions, there was no association between primary control engagement coping 
and HbA1c in this study (r = -.14, p > .05).  There was a moderate negative relationship between 
secondary control engagement coping and HbA1c (r = -.31, p < .01), indicating that greater 
levels of secondary control engagement coping were related to lower HbA1c values.  
Disengagement coping was also significantly correlated with HbA1c, but in the expected 
positive direction (r = .24, p < .05).  Though a somewhat weaker correlation, this indicates that 
patients reporting the use of disengagement coping had higher HbA1c values.   
 
Validation of the RSQ  
The final set of hypotheses involves validating the RSQ in a sample of type 2 adult 
diabetes patients.  To test these hypotheses, confirmatory factor analyses were used, as well as 
correlations among internal factors and with the Brief COPE.   
Correlations among RSQ factors.  The correlations of the RSQ coping and involuntary 
stress response factors were examined using both correlations among raw scores and correlations 
among proportion scores (see Table 8).  Correlations among raw scores indicated that primary 
and secondary control engagement coping were positively correlated with one another (r = 0.44, 
p < .01) but did not have significant correlations with the other factors.  Disengagement coping, 
involuntary engagement and involuntary disengagement were all strongly positively correlated 
with one another (r’s ranged from 0.70 to 0.82, p < .01).   
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Table 7.  Correlations Among RSQ Coping Factors, the CES-D, HBA1c, the PAID-2 and the SDSCA. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1.  Primary Control  -                
2.  Secondary Control  .27
** 
-               
3.  Disengagement Coping -.48
**
 -.48
**
 -              
4.  CES-D -.46
**
 -.51
**
 .27
**
 -             
5.  HBA1C -.14 -.31
**
 .24
*
 .10 -            
6. PAID Interpersonal -.43
**
 -.58
**
 .30
**
 .44
**
 .23
*
 -           
7. PAID Regimen -.43
**
 -.57
**
 .53
**
 .38
**
 .26
**
 .84
**
 -          
8. PAID Physician -.32
**
 -.55
**
 .21
*
 .44
**
 .43
**
 .71
**
 .66
**
 -         
9. PAID Emotional -.40
**
 -.68
**
 .33
**
 .52
**
 .30
**
 .92
**
 .73
**
 .74
**
 -        
10. PAID Total -.47
**
 -.71
**
 .46
**
 .51
**
 .34
**
 .85
**
 .84
**
 .71
**
 .92
**
 -       
11. SDSCA Diet .37
**
 .30
**
 -.45
**
 -.25
**
 -.10 -.22
*
 -.54
**
 -.11 -.34
**
 -.40
**
 -      
12. SDSCA Blood Sugar Testing .15 .11 -.32
**
 -.09 -.01 .07 -.35
**
 .05 .05 -.11 .37
**
 -     
13. SDSCA Foot Checking .23
*
 .06 -.19
*
 -.15 -.01 .04 -.23
*
 .04 -.10 -.08 .27
**
 .15 -    
14. SDSCA Exercise .24
*
 .19
*
 -.34
**
 -.10 -.15 -.01 -.41
**
 .05 -.26
**
 -.23
*
 .37
**
 .11 .25
**
 -   
15. SDSCA Total .39
**
 .24
*
 -.49
**
 -.22
**
 -.06 .06 -.45
**
 .07 -.09 -.30
**
 .80
**
 .66
**
 .63
**
 .51
**
 -  
16. Total complications -.12 -.06 .07 .01 .18 .07 -.01 .01 .07 .15 -.02 .11 -.02 -.20
*
 .02 - 
*p < .05,  **p < .01 
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Correlations of proportion scores reflected a different overall pattern of associations.  
While primary control engagement and secondary control engagement coping were again 
positively associated with each other (r = .27, p < .01), they were also negatively correlated with 
disengagement coping (r = -0.48 and r = -0.48 respectively, p < .01) and the two involuntary 
response scales (r’s ranged from -0.59 to -0.73, p < .01).  Disengagement coping was positively 
correlated with involuntary disengagement (r = 0.33, p < .01).  Involuntary engagement and 
involuntary disengagement also had a significant, positive association (r = 0.60, p < .01).  As 
seen in prior studies of the RSQ (Compas et al., 2006), proportion scores followed the overall 
conceptual model more closely. Primary and secondary control engagement coping showed more 
differentiation from disengagement coping and involuntary stress scales.    
 
Table 8. Correlations Between RSQ Raw and Ratio Scores.   
  1 2 3 4 5 6 7 8 9 10 
1.  Primary control raw - 
         
2.  Secondary control raw   .44
**
 - 
        
3.  Disengagement raw -.17 .03 - 
       
4.  Involuntary     
    disengagement raw 
-.15 -.01 .73
**
 - 
      
5.  Involuntary  
    disengagement raw 
-.03 .01 .70
**
 .82
**
 - 
     
6.  Primary control ratio   .75
**
 .08 -.56
**
 -.57
**
 -.52
**
 - 
    
7.  Secondary control ratio .02 .44
**
 -.64
**
 -.70
**
 -.73
**
 .27
**
 - 
   
8.  Disengagement ratio  -.44
**
 -.29
**
 .68
**
 .32
**
 .20
*
 -.48
**
 -.48
**
 - 
  
9.  Involuntary engagement  
     Ratio 
-.29
**
 -.32
**
 .44
**
 .60
**
 .84
**
 -.62
**
 -.69
**
 .18 - 
 
10. Involuntary  
     disengagement ratio 
-.28
**
 -.17 .65
**
 .93
**
 .70
**
 -.59
**
 -.73
**
 .33
**
 .60
**
 - 
*p < .05,  **p < .01 
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Confirmatory Factor Analysis. To examine the factor structure of the RSQ, Mplus 
software (version 6.0) was used.  Missing data were handled using the maximum-likelihood 
procedure.  Multiple indices were used to assess the fit of the data to the hypothesized model.  
Chi-square tests that compare the covariance matrix of the observed variables with the matrix 
implied by the specified model are reported (Hu & Bentler, 1995).  However, as Chi-square can 
be affected by both sample size and model size, additional fit indices are provided:  Bentler’s 
Comparative Fit Index (CFI) and Steiger’s Root Mean Square Error of Approximation (RSMEA) 
(Bentler, 1990; Steiger, 1990).  The CFI compares the fit of a target model to the fit of an 
independent model in which the variables are assumed to be uncorrelated. In this context, fit 
refers to the difference between the observed and predicted covariance matrices, CFI values 
above 0.95 are considered a good fit, while values above 0.90 are considered an adequate fit (Hu 
& Bentler, 1999).  RMSEA expresses fit per degree of freedom of the model; values of RMSEA 
of less than 0.08 imply an acceptable model and values of less than 0.05 imply a good fit (Hu & 
Bentler, 1999).  Prior studies using the five-factor RSQ produced fit indices ranging from CFI = 
0.87 – 0.99 and RMSEA = 0.9 – 0.7 (Benson et al., 2011; Wadsworth et al., 2004).  Fit indices 
for the current study revealed an adequate fit for the five-factor model of the RSQ (χ2(142) = 
246.53, p < .001, CFI = .91, RMSEA = .08).  Figure 1 contains the correlated five-factor model.     
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Secondary Control  
Engagement 
 Coping 
Disengagement 
 Coping 
Involuntary 
Engagement 
Involuntary  
Disengagement 
Problem Solving 
Emotional Regulation 
Emotional Expression 
Cognitive Restructuring 
Positive Thinking 
Acceptance 
Distraction 
Denial 
Avoidance 
Wishful Thinking 
Emotional Numbing 
Cognitive Interference 
Inaction 
Escape 
Rumination 
Intrusive Thoughts 
Physiological Arousal 
Emotional Arousal 
Involuntary Action 
.76*
 
.76* 
.59* 
 .76* 
.95* 
.60* 
  .57* 
.79* 
.63* 
.82* 
  .77* 
.63* 
.76* 
  .87* 
  .89* 
.79* 
.74* 
.77* 
.70* 
.70* 
-.31* 
-.06 
.77* 
.92* 
-.04 
.95* 
-.11 
.-.06 
-.24* 
.43* 
.65* 
.41* 
.42* 
.11 
.64* 
 .68* 
.38* 
 .61* 
.33* 
.36* 
.45* 
.41* 
.51* 
.40* 
  .60* 
.43* 
.21* 
.25* 
Figure 1.  Confirmatory Factor Analysis of the Five-factor RSQ 
*p < .01 
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Correlations with the Brief COPE.  The convergent and discriminant validity correlations 
between the RSQ and the brief COPE are presented in Table 9.  The correlations represent both 
convergent validity between scales that represent similar constructs on the RSQ and the brief 
COPE and discriminant validity between scales that represent different constructs on the two 
measures.  The primary control engagement coping factor on the RSQ was significantly related 
to nine scales on the Brief COPE.  Seven of these scales (active coping, instrumental support, 
emotional support, venting, positive reframing, planning, and acceptance) were either within or 
greater than the range of .30 to .50 that is expected for these types of analyses (Fiske & 
Campbell, 1992).  The strongest correlations were between instrumental support (r = 0.59, p < 
.01) and emotional support (r = 0.54, p < .01).  Conversely, primary control engagement coping 
was not correlated with scales that represented different constructs (e.g. behavioral 
disengagement, self-blame).   
The secondary control engagement scale on the RSQ was also significantly related to 
nine scales on the brief COPE, four of which (active coping, emotional support, positive 
reframing and acceptance) exceeded the threshold of .30.  Positive reframing (r = 0.40, p < .01) 
and acceptance (r = 0.40, p < .01) had the highest correlations with secondary control 
engagement coping.  Constructs more closely aligned with disengagement coping (e.g. 
behavioral disengagement, self-blame) were not significantly related to this factor.   However, 
secondary control engagement coping was difficult to differentiate from primary control 
engagement coping, as they both shared positive and significant correlations with the same nine 
COPE scales.   
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Finally, disengagement coping was significantly correlated with five COPE scales, with 
four significant correlations (self-distraction, denial, behavioral disengagement and self-blame) 
being greater than .30.  Scales with different constructs (e.g. acceptance, positive reframing, and 
emotional support) were not correlated with disengagement coping.  However, two scales 
reached significance that were not expected to be part of the pattern of convergent validity:  
active coping (r = .22, p < .05) and planning (r = .29, p < .01).  These correlations were both 
weak and did not exceed .30.    
 
Table 9. Convergent and Discriminant Validity Correlations between RSQ and the Brief COPE.   
Brief COPE 
Primary 
Engagement 
Coping 
Secondary 
Engagement 
Coping 
Disengagement 
Coping 
Self-distraction .15 .14 .52
**
 
Active coping .35
**
 .35
**
 .22
*
 
Denial .07 .05 .37
**
 
Emotional support .54
**
 .31
**
 .08 
Instrumental support .59
**
 .24
*
 -.02 
Behavioral disengagement -.18 -.06 .42
**
 
Venting .43
**
 .23
*
 .18 
Positive Reframing .46
**
 .40
**
 .16 
Planning .31
**
 .27
*
 .29
**
 
Humor .29
**
 .27
**
 .07 
Acceptance .39
**
 .40
**
 -.01 
Religion .29
**
 .25
**
 .02 
Self-blame -.11 -.09 .55
**
 
Substance Use -.01 .03 .13 
*p < .05,  **p < .01 
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CHAPTER IV 
 
DISCUSSION 
 
The present study focused on identifying and clarifying the relationship between 
depressive symptoms, coping strategies, self-care behaviors, diabetes-related distress and 
metabolic control in a sample of type 2 diabetes patients.  Depressive symptoms were assessed 
using the CES-D, while the SDSCA was used to measure self-care behaviors and the PAID-2 
measured diabetes-related distress.  HbA1c, a standard measure of metabolic control, was 
included to provide information on average blood glucose levels over the past three months.  
Finally, the RSQ was used to measure voluntary coping strategies.  As the RSQ has previously 
been used in adolescent diabetes patients and adult women with breast cancer, an additional aim 
of this study was to validate the Responses to Stress Questionnaire (RSQ) in an adult sample of 
type 2 diabetes patients. 
Previous research on coping patterns in patients with diabetes found that problem-
focused coping strategies (e.g. active coping, planning) were related to  lower levels of 
depressive symptomatology (Macrodimitris & Endler, 2001) and lower HbA1c levels (Graue, 
Wentzel-Larsen, Bru, Hanestad, & Sovik, 2004; Rose, Fliege, Hildebrandt, Schirop, & Klapp, 
2002; Sultan & Heurtier-Hartemann, 2001).  Conversely, specific emotion-focused coping 
strategies (e.g. disengagement, avoidance) were associated with increased symptoms of 
depression, poorer metabolic control and poorer quality of life (Coelho, Amorim, & Prata, 2003; 
Macrodimitris & Endler, 2001).  However, as some emotion-focused coping strategies may be 
considered adaptive (e.g. positive reappraisal) and others maladaptive (e.g. avoidance), the 
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previous findings may have been adversely affected by errors in measurement of emotion-
focused coping.   
 
Hypothesis Testing 
The main findings from this study support and extend the existing literature.  Both 
primary control engagement coping and secondary control engagement coping were found to be 
related to depressive symptom scores.  As measured by the RSQ, primary control engagement 
coping assesses ways that individuals attempt to directly change the source of stress or one’s 
emotional responses to the stressor (e.g. problem solving, emotional modulation and emotional 
expression) (Compas et al., 2006).  Secondary control engagement coping measures indirect 
coping processes designed to alter emotional responses to a stressor (e.g. positive thinking, 
cognitive restructuring, acceptance and distraction) (Compas et al., 2006).  In this study, primary 
control engagement coping and secondary control coping were both negatively correlated with 
depressive symptoms and explained a significant portion of the variance in CES-D scores.  Thus, 
higher amounts of primary control and secondary control engagement coping were associated 
with lower levels of depressive symptoms.   
As problem solving has previously been associated with fewer depressive symptoms in 
diabetes patients (Macrodimitris & Endler, 2001), primary control engagement coping was 
expected to have a negative relationship with depression.  However, primary control engagement 
coping also encompasses certain active emotion-focused coping strategies (e.g. emotional 
modulation and emotional expression) and secondary control coping almost exclusively focuses 
on coping with the emotional reaction to a stressor.  Contrary to other studies finding that 
emotion-focused coping is positively associated with depression (Maes et al., 1996), results from 
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the current study showed that specific emotion-focused coping strategies were associated with 
lower levels of depressive symptoms.  For example, a person with diabetes who chooses to 
reframe a diabetes-related stressor in a different light may be less prone to negative thoughts 
(e.g. choosing to tell themselves that an episode of high blood sugar is a correctable problem 
rather than example of personal failure).  Certain emotion-focused coping strategies may be 
considered adaptive rather than maladaptive in patients with diabetes.   
Disengagement coping, on the other hand, measures efforts to avoid or suppress the 
source of stress and/or the emotional responses to a stressor (Connor-Smith et al., 2000).  
Disengagement coping is comprised of coping processes such as avoidance, wishful thinking and 
denial.  In the current study, disengagement coping was positively correlated with depressive 
symptoms, such that increased use of disengagement coping was associated with higher 
depressive symptoms.  However, disengagement coping did not explain a significant proportion 
of the variance in regression analyses.  This is a somewhat surprising finding, as previous studies 
have found a relationship between depression and the use of avoidance as a coping strategy 
(Coelho et al., 2003; Macrodimitris & Endler, 2001).  In part, this result may be due to the fact 
that the sample was educated, affluent and well-employed.  Persons with these characteristics 
may already tend to employ adaptive coping skills across many life domains, including 
management of their diabetes, and avoid use of maladaptive coping strategies.   
A second aim of this study was to examine the relationship between depressive 
symptoms and diabetes outcomes, such as diabetes-related distress, self-care behaviors and 
metabolic control.  A significant association was found between the CES-D and the PAID-2, 
including total scores and all subscales on the PAID-2.  Thus, higher levels of depressive 
symptoms were associated with higher diabetes-related distress, particularly in regards to 
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emotions surrounding the disease (e.g. feeling “worried” or “burned out” by having diabetes).  
This result supports the existing literature, as prior research has found that diabetes patients with 
existing depression may be concurrently experiencing higher levels of diabetes-related distress 
(Hermanns, Kulzer, Krichbaum, Kubiak, & Haak, 2006; Lloyd, Pambianco, & Orchard, 2010).  
The direction of this association is not well-understood; it remains unclear whether problems 
with diabetes invoke a depressive emotional style (e.g. helplessness and negative thinking) or if 
the presence of depression itself creates perceived diabetes- related distress.   This result may 
also be due to a measurement artifact, such that there is an overlap in constructs.  While the 
PAID is designed to be a measure of diabetes-related distress, it may also be picking up on 
overall distress that is not limited to having diabetes.   
When examining depressive symptoms and diabetes self-care behaviors, significant but 
somewhat weak negative associations were found between the CES-D and the overall SDSCA 
score (r = -0.22, p < .01), indicating that diabetes patients with higher depressive scores were less 
likely to report following prescribed self-care guidelines.  Again, this finding replicates findings 
in the existing literature (Ciechanowski et al., 2000; L. E. Egede, Ellis, & Grubaugh, 2009; 
Jahan, Jabbar, Naqvi, & Awan, 2011).  Intuitively, this is an expected result, as persons who are 
depressed generally function at a lower level and are less active than their non-depressed 
counterparts (Hays, Wells, Sherbourne, Rogers, & Spritzer, 1995; Judd, Paulus, Wells, & 
Rapaport, 1996; Rhebergen et al., 2010).   However, the SDSCA may also be a limited measure 
of adherence, as it is a very brief measure and limits in-depth examination of the various aspects 
of each self-care domain.   Additionally, the SDSCA may be predicting the perception of 
adherence rather than actual behavior.  A more specific measure of self-care behaviors, such as 
the Personal Diabetes Questionnaire (Stetson et al., 2011), may be a better tool for future studies.   
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Finally, the relationship between depressive symptom scores and metabolic control (as 
measured by HbA1c) was investigated.  Contrary to predictions, there was no association 
between the CES-D and HbA1c in this study.   Prior research has been somewhat equivocal 
when examining the relationship between depression and HbA1c.  Some studies found diabetes 
patients with higher levels of depression had worse metabolic control (Lustman et al., 2000; 
Papelbaum et al., 2011), while other studies found no such relationship (de Groot, Jacobson, 
Samson, & Welch, 1999).  From a methodological standpoint, there does not appear to be a 
problem with restricted range on either CES-D scores or HbA1c values in the current study, 
though the timeframe of measurement may have played a role (see limitations, below).  It may 
also be possible that persons who obtain good medical care (i.e. from a specialized diabetes 
clinic at Vanderbilt) may receive more aggressive disease treatment, particularly in the form of 
medication.  Thus, their blood glucose levels may be controlled somewhat independently of 
psychological adjustment and self-care behavior. 
The third set of hypotheses examined the relationship between voluntary coping (e.g. 
primary control, secondary control and disengagement coping) and diabetes-related outcomes, 
including diabetes-related distress, self-care behaviors and metabolic control (HbA1c). 
Significant negative correlations were found between positive control and secondary control 
engagement coping and diabetes-related distress.  Thus, higher amounts of both primary and 
secondary control coping were associated with lower amounts of diabetes-related distress.  
Secondary control engagement coping in particular was highly negatively correlated with the 
“emotional distress” subscale of the PAID-2, indicating that patients were less likely to have 
emotional distress about their diabetes if they employed coping strategies such as positive 
thinking or cognitive restructuring.  Also in line with predictions, disengagement coping was 
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positively correlated with scores of diabetes-related distress. Thus, the use of maladaptive coping 
strategies (such as avoidance or denial) was related to higher levels of diabetes-related distress in 
this sample of type 2 diabetes patients.   
Associations between coping and diabetes self-care behaviors were also examined.  
Significant but moderate positive associations were found between primary control engagement 
coping and most diabetes self-care behaviors, with the exception of blood sugar testing.  Thus, 
patients who use coping strategies designed to actively control the source of stress (e.g. problem 
solving) are more likely to report engaging in recommended self-care behaviors.  Associations 
between secondary control engagement coping and self-care behavior were less robust, as 
significant positive correlations were found only with total self-care scores and subscales relating 
to diet and exercise.  As expected, disengagement coping was negatively correlated with all 
diabetes self-care behaviors.  Thus, patients who used greater disengagement coping (e.g. 
avoidance, denial) were less likely to report following recommended self-care behaviors.   
Additionally, the association between coping variables and metabolic control were 
examined.  Contrary to predictions, there was no association between primary control 
engagement coping and HbA1c in this study.   As primary control engagement coping measures 
more active coping strategies (i.e. problem-solving), and problem-solving has been previously 
linked to greater metabolic control (Smari & Valtysdottir, 1997; Sultan & Heurtier-Hartemann, 
2001), this was a somewhat surprising finding.   However, results indicated that there was a 
significant negative correlation between secondary control engagement coping and HbA1c.  
Thus, patients who reported using greater levels of secondary control engagement coping 
strategies such as positive thinking and cognitive restructuring had lower HbA1c values.  
Additionally, disengagement coping was also positively correlated with HbA1c, indicating that 
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patients who endorsed using coping strategies such as avoidance or denial had poorer metabolic 
control.     
A final aim of the study was to validate the RSQ in a sample of adult type 2 diabetes 
patients.  This measure of coping has been used previously in studies of adolescents (Connor-
Smith et al., 2000), adolescents with type I diabetes (Jaser & White, 2011) and adults with breast 
cancer (Compas et al., 2006), but it has not yet been validated in adults with type 2 diabetes.  A 
confirmatory factor analysis was performed to examine the full five-factor model of the RSQ in 
this sample, including voluntary coping strategies (e.g. primary control engagement coping, 
secondary control engagement coping, disengagement coping) and involuntary responses to 
stress (e.g. involuntary engagement and involuntary disengagement).  Fit indices revealed that 
the five-factor model was an adequate fit to the data, indicating that the factor structure holds in 
this population.   
Convergent and discriminant validity was examined using correlations between the RSQ 
and the Brief Cope.   The RSQ factors generally followed the expected pattern of correlations 
with the Brief Cope scales: primary control engagement coping was strongly correlated with 
instrumental support (r = 0.59, p < .01) and emotional support (r = 0.54, p < .01), secondary 
control engagement coping was strongly correlated with positive reframing (r = 0.40, p < .01) 
and acceptance (r = 0.40, p < .01), and disengagement coping was correlated with self-distraction 
(r = 0.52, p < .01) and behavioral disengagement (r = 0.42, p < .01).  However, there was some 
overlap in patterns of correlations, particularly between the Brief Cope scales and RSQ factors of 
primary control and secondary control engagement coping.  Both RSQ factors significantly 
correlated with the same nine scales on the Brief Cope, albeit in different strengths of 
correlation.  Thus, there was some challenge in differentiating between the two factors.   
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Though this was not a main focus of the current study, an interesting finding was the 
relative lack of gender differences among most of the variables in the study, including depressive 
symptoms, metabolic control and self-care behaviors.  Women generally scored higher than men 
on measures of diabetes-related distress, though this was not significant at the p < .05 level (p < 
.07).  The only statistically significant difference was found in raw scores of primary control 
engagement coping; however, this result was not found when examining proportion scores.  
Thus, when proportion scores were calculated to remove a “yea-saying” response bias, no gender 
differences were found.   
 
Study Limitations  
Sampling bias may have been a limitation in this study, as the majority of participants 
were Caucasian, well-educated and reasonably affluent.  Over half of the participants (58.9%) 
had graduated from college and/or had a graduate degree, and at least 61% of the sample had 
household incomes of $50,000 or more.  As such, the homogeneity of the sample may limit the 
generalizability of the results. Prevalence rates of diabetes are higher in other ethnic populations 
(e.g. African Americans, Hispanic Americans, American Indians/Alaska Natives) than 
Caucasians (ADA, 2005).  Diabetes patients with a lower socioeconomic status may have 
additional challenges that would impact their responses, as previous studies have linked lower 
socioeconomic status with poorer health outcomes and higher depressive symptoms (Adler et al., 
1994).    
Furthermore, study methodology and data collection challenges may have had an impact 
on the findings.  The study was based on self-report questionnaires (e.g. coping, depressive 
symptoms, self-care behaviors, and diabetes-related distress).  Self-report questionnaires, being 
subjective by their very nature, may be less effective in obtaining unbiased data.  However, there 
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is some evidence to suggest that self-report data correlates with objective health outcomes 
(Finch, Hummer, Reindl, & Vega, 2002; Idler & Benyamini, 1997).  Sample size may have also 
played a role in some of the findings, particularly when examining the factor analysis of the 
RSQ.  The full sample had 116 participants, a size with enough data to confidently examine 
relationships between variables (e.g. depressive symptoms and coping strategies).  However, a 
much larger sample size would have increased statistical power and may have given more 
reliable results when analyzing the factor structure of the RSQ.  Even with the small sample, fit 
indices indicated an adequate fit to the data (RMSEA = .08, CFI = .91).   
Obtaining recent data about metabolic control (e.g. HbA1c values) presented another 
challenge in regards to methodology.  Ideally participants would have been recruited on-site at 
the Vanderbilt diabetes clinic and would have been given an HbA1c test on (or within days of) 
completing the study questionnaire.  As on-site recruitment was not an option for this study, 
participants’ most recent HbA1c value was obtained from their medical record.  These values 
may have been obtained by the medical clinic up to six weeks before the participant completed 
the questionnaire, and HbA1c readings themselves are a measure of average blood sugar over a 
three-month timeframe.  The time discrepancy between obtaining the HbA1c values and getting 
a snapshot of current (past-week) depressive symptoms may have led to weak findings in this 
study.    
Finally, the use of cross-sectional data presented a limitation in this study. Cross-
sectional studies assess symptoms, health status and outcomes of participants at one point in 
time.  Cross-sectional studies do not account for changes over time and have limited ability to 
evaluate the progressive nature of a chronic illness. Type 2 diabetes is a complex disease that 
requires patients to adapt and cope with both daily health issues (e.g. episodes of low or high 
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blood sugar) and longer-range problems (e.g. diabetes complications). Longitudinal research 
may reveal a more accurate picture of the influence that coping strategies have on depressive 
symptoms and patient outcomes in type 2 diabetes. 
 
Implications for Theory and Practice 
The current study has multiple implications for both theory and practice.  In terms of 
theory, results from this study highlighted the importance of evaluating emotion-focused coping 
in more specific factors, rather than aggregating all emotion-focused coping into one overarching 
category.  Certain emotion-focused coping strategies may be considered adaptive in patients with 
type 2 diabetes.  For example, positive thinking, cognitive restructuring, and emotional 
modulation may all serve to change negative emotions towards diabetes-related stressors, thus 
possibly serving as a protective factor against depression and depressive symptoms.  Conversely, 
use of other emotion-focused coping processes, such as avoidance or denial, may be considered 
maladaptive in patients with type 2 diabetes.  Prior measures of coping were less able to 
distinguish between these emotion-focused strategies.  The RSQ provides a means of measuring 
these coping mechanisms in a more effective manner and is better suited for use with samples of 
adult diabetes patients than pre-existing measures of coping.    
In terms of practice, the results from this study have implications across a wide variety of 
realms, including assessment, diabetes education and behavioral health practices (e.g. coping 
skills training, cognitive-behavioral therapy and other psychological treatment).  Psychological 
factors such as depressive symptoms and coping strategies may influence lifestyle behavior 
choices and quality of life of individuals with type II diabetes.  Results from this study may also 
have implications for overall health care management and expenditures.   
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Assessment.  The results from this study indicate that proper assessment of coping 
strategies and depressive symptoms are important in a clinical setting.  Given the high 
prevalence rates of depression in diabetes patients and the negative outcomes of the untreated 
condition, a brief screen for depression should be administered during patient visits.  While the 
CES-D is routinely used for research studies, the 2-item Patient Health Questionnaire (PHQ-2) 
could serve as a clinical screening tool (Kroenke, Spitzer, & Williams, 2003).  Additionally, 
trained practitioners may want to assess their patients’ current use of coping strategies.  The 
findings from this study suggest that assessing for specific voluntary coping strategies (e.g. 
primary/secondary control engagement vs. disengagement) may be useful to aid in possible 
psychoeducation and coping skills training 
Diabetes Education and Management.  Having diabetes generally requires individuals to 
make significant lifestyle changes to manage their diabetes to prevent acute and chronic 
complications. Diabetes self-management training is integral in providing individuals with the 
skills to manage their disease on a daily basis. Recent guidelines for diabetes management 
produced by the American Association of Diabetes Educators (AADE7) recommends that 
individuals should choose self-care goals based on the following areas 1) healthy eating; 2) being 
active; 3) blood glucose monitoring; 4) taking medication; 5) problem solving; 6) healthy 
coping; and 7) reducing risks (AADE, 2008).  As highlighted in the AADE7 guidelines, both 
problem solving (a method of primary control engagement coping) and “healthy coping” are 
seen as essential components of diabetes self-management (AADE, 2008).    
While health care practitioners (e.g. diabetes educators, doctors, nurses) are often adept at 
teaching individuals appropriate self-management strategies in the realm of diet, exercise, blood 
glucose monitoring, and medication adherence to maintain glycemic control, they may be poorly 
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prepared to address areas of psychological adjustment and coping.  Training practitioners in 
coping skills and psychological interventions and/or adding skilled behavioral medicine 
specialists (e.g. psychologists, social workers) to clinical staff may help in the overall treatment 
of diabetes patients.  The addition of coping skills training and behavioral medicine interventions 
to routine health care services may significantly enhance diabetes self-management.   
Coping Skills Training.  The AADE7 defined healthy coping as ‘‘…responding to a 
psychological and physical challenge by recruiting available resources to increase the probability 
of favorable outcomes in the future.’’ (Kent et al., 2010).  Prior research has found that coping 
skills training has been successful in increasing self-care behaviors, decreasing emotional 
distress, reducing A1c levels, and improving quality of life in individuals with diabetes (E. B. 
Fisher, Thorpe, DeVellis, & DeVellis, 2007; Grey et al., 1998; Melkus et al., 2010).  Coping 
skills training may help diabetes patients successfully manage their disease by enhancing their 
abilities to cope both directly (e.g. primary control engagement coping) and indirectly (e.g. 
secondary control engagement coping) to the stress of having diabetes.  Health care practitioners 
should concurrently examine use of existing coping strategies while also encouraging patients to 
use more adaptive coping skills (e.g. problem solving, cognitive restructuring, emotional 
modulation) rather than maladaptive coping (e.g. avoidance, denial).  By implementing coping 
skills training, diabetes patients may feel more empowered to face daily challenges in living with 
diabetes, and may thus reduce their risk of developing depressive symptoms.  
Cognitive Behavioral Therapy.  Health care practitioners can assist individuals in 
managing depressive symptoms and emotional distress by using Cognitive Behavioral Therapy 
(CBT) techniques.  CBT is based on the idea that inaccurate beliefs and cognitive distortions 
have a role in the development and maintenance of depression. This model suggests that 
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correcting maladaptive thinking will diminish depressive symptomatology and reduce risk for 
relapse.  As such, CBT focuses on modifying emotions and improving behaviors by helping 
patients to identify and challenge dysfunctional beliefs, adopt appropriate beliefs and test new 
beliefs and behaviors in real-life situations (Beck, Rush, & Shaw, 1979).  
Studies on treatment of depression in the general population have found that CBT is 
efficacious in treating major depressive disorder and preventing subsequent relapse (Dobson et 
al., 2008; Driessen & Hollon, 2010).  Previous research also supports the effectiveness of CBT in 
persons with comorbid depression and diabetes (Snoek et al., 2001; van Bastelaar, Pouwer, 
Cuijpers, Riper, & Snoek, 2011).  As the comorbidity between diabetes and depression is 
associated with negative outcomes (e.g. increased complications, higher health care 
expenditures, increased risk of mortality), remittance of depression should be viewed as an 
imperative treatment goal in this population.   
Implications for Healthcare.  Diabetes creates vast health care costs that affect both 
individuals and overall health care expenditures in the United States. In the year 2007, the total 
annual medical expenditures attributed to diabetes were estimated to be $174 billion (ADA, 
2008). Medical costs attributed to diabetes include $27 billion for direct diabetes care, $58 
billion to treat chronic diabetes-related complications, and $31 billon in excess general medical 
costs. (ADA, 2008).  Individuals diagnosed with diabetes incur average medical expenditures of 
$11,744 per year, and on average have health care costs that are 2.3 times higher than their non-
diabetic counterparts (ADA, 2008).  Comorbid depression and diabetes has also been shown to 
additionally increase health care expenditures (Ciechanowski et al., 2000; Leonard E. Egede et 
al., 2002). 
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Prevention of acute and chronic complications and treatment of comorbid depression 
could have substantial effects on health care expenditures. State and federally funded programs 
for diabetes education and care should be developed and implemented along with psychological 
interventions that are effective across the course of the disease process. Further knowledge on 
how psychological adjustment and use of coping strategies influence diabetes outcomes may 
enhance the development of appropriate treatment regimens and psychological interventions.  
Strategies to improve self-care behavior and glycemic control will assist in decreasing acute and 
chronic complications, leading to an improved quality of life for individuals with type 2 diabetes. 
 
Future Research 
As previously noted, the cross-sectional nature of this study presents a limitation in 
drawing causal connections between coping, depressive symptoms and diabetes outcomes.  From 
the data presented, we can infer associations between the variables, but we do not fully 
understand the causal relationships among the variables.  The pathways remain unclear:  does the 
use of specific coping strategies serve as a risk or protective factor against incident depression, 
does the presence of depressive symptoms affect the use of coping strategies, or is there a 
bidirectional relationship?  What are the temporal relationships between coping, depressive 
symptoms and diabetes outcomes? Longitudinal studies may be able to shed new light on these 
relationships, and as such lead to more well-developed theoretical models and targeted 
psychosocial interventions. 
Finally, future research would include psychological epidemiological studies to help 
further understand the relationship between coping, depressive symptoms and diabetes-related 
outcomes (e.g. self-care behaviors, metabolic control and diabetes-related distress).  Additional 
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targeted intervention studies should be developed for this population:  for example, interventions 
that combine coping skills training and diabetes education to help improve adherence and 
possibly reduce the risk of incident depression.  Training programs for diabetes educators, nurses 
and other health care practitioners should be also developed and implemented to help adequately 
disseminate psychosocial interventions.  As type 2 diabetes is a rapidly-growing health care issue 
in the United States, and comorbid depression in patients with diabetes has negative outcomes, it 
is vital for researchers to continue to focus on ways to increase effective coping, treat current 
depression, reduce the risk of incident depression and/or relapse, and promote good self-care 
behaviors in this population.   
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APPENDICES 
 
Appendix A.  Recruitment email  
 
 
Type 2 Diabetes Research Study 
 
All adults ages 18-75 with type 2 diabetes are asked to consider taking part in a Vanderbilt 
research study about emotions, coping styles and health.  Volunteers must have been diagnosed 
with type 2 diabetes for at least six months or more, must receive their diabetes care through a 
Vanderbilt clinic and be proficient in English. The study involves completing surveys about 
emotions, coping styles and diabetes-related health activities.   The surveys take approximately 
25-40 minutes to complete.    
 
Eligible participants will receive compensation for participation in the form of a $10 gift 
certificate to Target.  Additionally, all participants will be entered into a drawing to receive a 
$250 gift certificate for travel on Southwest Airlines at the conclusion of the study.  All 
information gathered in the study will be kept confidential and used for research purposes only.   
 
If you are interested in participating in the study, you may complete the online surveys at the 
following website: 
https://redcap.vanderbilt.edu/surveys/?s=uQzVKr 
 
Interested participants may also choose to receive a paper version of the study via US mail, along 
with a self-addressed, stamped envelope for return.  If you would like to learn more about this 
study or request a paper packet, please contact: 
 
Hollister Trott 
hollister.trott@vanderbilt.edu 
(919) 794-1157 
 
 
*Please note that this is an ongoing research project.  If you have already taken the survey, thank 
you for your time.  Only one survey per participant is needed.* 
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Appendix B.  Survey Flyer 
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Appendix C.  Demographic information, health information, mental health information 
 
Demographic Information 
What is your date of birth?   
What is your gender?   
Male 
Female 
What is your racial or ethnic origin?  
Caucasian 
African-American 
Hispanic 
Asian 
Pacific Islander 
Other 
What is your overall household income?  
Less than $25,000 per year 
$25,000 - $50,000 per year 
$50,000-$75,000 per year 
$75,000-$100,000 per year 
Over $100,000 per year 
What is your marital status? 
Single 
Not married but living with partner 
Married 
Separated 
Divorced  
Widowed 
What is the highest level of education that you completed?  
Less than 9th grade 
Some high school 
Graduated high school 
Some college 
Technical school or associate’s degree 
Graduated college 
Post-graduate degree 
Are you currently employed?   
 Yes 
 No 
If yes, how many hours per week? 
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Health information 
How tall are you (in inches)? 
How much do you weigh (in pounds)? 
How long have you been diagnosed with type 2 diabetes? 
Less than 6 months 
6 months to 1 year 
1 year to 5 years 
5 years to 10 years 
Over 10 years 
What kinds of medications do you currently take for diabetes? 
Oral medications 
Insulin 
Both oral medications and insulin 
None 
Are you experiencing any diabetes complications? If yes, check off all that apply: 
  Heart disease 
  Kidney disease 
  Eye problems 
  Peripheral vascular disease 
  Neuropathy or nerve damage  
  Gum disease 
  Foot problems 
Do you have any other chronic medical illnesses? 
Do you smoke?  
Yes 
No 
If yes, on average how many cigarettes per day? 
Do you drink alcohol?  
Yes 
No   
If yes, approximately how many drinks per week?  
 
 
Mental Health information 
Are you currently diagnosed with any mental health conditions (e.g. depression, anxiety, bipolar 
disorder)?   
Yes 
No   
If yes, please list the diagnosis: 
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Are you receiving treatment for this condition?  
Yes 
No   
If yes, what kind of treatment (e.g. medications, therapy, alternative therapy)? 
Have you been diagnosed in the past with depression, anxiety, bipolar disorder, or any other 
mental health conditions? (Please list diagnosis if applicable) 
Yes 
No 
If depression is yes: 
 How many estimated episodes of depression have you experienced? 
How old were you when you had your first episode of depression? 
Have you ever received any type of treatment for depression (e.g. medications, therapy, 
alternative therapy)?   
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Appendix D.  The Center for Epidemiologic Studies Depression Scale (CES-D). 
 
Circle the number of each statement which best describes how often you felt or behaved 
this way – DURING THE PAST WEEK. 
 Rarely or 
none of the 
time (less 
than 1 day) 
Some or a 
little of the 
time (1-2 
days) 
Occasionally or 
a moderate 
amount of the 
time (3-4 days) 
Most or all 
of the time 
(5-7 days) 
During the past week: 0 1 2 3 
1) I was bothered by things 
that usually don’t bother me 
0 1 2 3 
2) I did not feel like eating; 
my appetite was poor 
0 1 2 3 
3) I felt that I could not shake 
off the blues even with help 
from my family and friends 
0 1 2 3 
4) I felt that I was just as good 
as other people 
0 1 2 3 
5) I had trouble keeping my 
mind on what I was doing 
0 1 2 3 
6) I felt depressed 0 1 2 3 
7) I felt that everything I did 
was an effort 
0 1 2 3 
8) I felt hopeful about the 
future 
0 1 2 3 
9) I thought my life had been 
a failure 
0 1 2 3 
10) I felt fearful 0 1 2 3 
11) My sleep was restless 0 1 2 3 
12) I was happy 0 1 2 3 
13) I talked less than usual 0 1 2 3 
14) I felt lonely 0 1 2 3 
15) People were unfriendly 0 1 2 3 
16) I enjoyed life 0 1 2 3 
17) I had crying spells 0 1 2 3 
18) I felt sad 0 1 2 3 
19) I felt that people disliked 
me 
0 1 2 3 
20) I could not get “going” 0 1 2 3 
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Appendix D.   The Brief COPE. 
These items deal with ways you cope with the stress in your life that comes from having 
diabetes.  There are many ways to try to deal with problems.  These items ask what you've been 
doing to cope with this one.  Obviously, different people deal with things in different ways, but 
I'm interested in how you've tried to deal with it.  Each item says something about a particular 
way of coping.  I want to know to what extent you've been doing what the item says.  How much 
or how frequently.  Don't answer on the basis of whether it seems to be working or not—just 
whether or not you're doing it.  Use these response choices.  Try to rate each item separately in 
your mind from the others.  Make your answers as true FOR YOU as you can.  
 1 = I haven't been doing this at all  
 2 = I've been doing this a little bit  
 3 = I've been doing this a medium amount  
 4 = I've been doing this a lot  
1.  I've been turning to work or other activities to take my mind off things.  
2.  I've been concentrating my efforts on doing something about the situation I'm in.  
3.  I've been saying to myself "this isn't real." 
4.  I've been using alcohol or other drugs to make myself feel better.  
5.  I've been getting emotional support from others.  
6.  I've been giving up trying to deal with it.  
7.  I've been taking action to try to make the situation better.  
8.  I've been refusing to believe that it has happened.  
9.  I've been saying things to let my unpleasant feelings escape.  
10.  I’ve been getting help and advice from other people.  
11.  I've been using alcohol or other drugs to help me get through it.  
12.  I've been trying to see it in a different light, to make it seem more positive.  
13.  I’ve been criticizing myself.  
14.  I've been trying to come up with a strategy about what to do.  
15.  I've been getting comfort and understanding from someone.  
16.  I've been giving up the attempt to cope.  
17.  I've been looking for something good in what is happening.  
18.  I've been making jokes about it.  
19.  I've been doing something to think about it less, such as going to movies,  
 watching TV, reading, daydreaming, sleeping, or shopping.  
20.  I've been accepting the reality of the fact that it has happened.  
21.  I've been expressing my negative feelings.  
22.  I've been trying to find comfort in my religion or spiritual beliefs.  
23.  I’ve been trying to get advice or help from other people about what to do.  
24.  I've been learning to live with it.  
25.  I've been thinking hard about what steps to take.  
26.  I’ve been blaming myself for things that happened.  
27.  I've been praying or meditating.  
28.  I've been making fun of the situation.  
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Appendix E.  Summary of Diabetes Self-Care Activities (SDSCA). 
The questions below ask you about your diabetes self-care activities during the past seven days. 
If you were sick during the past seven days, please think back to the last seven days that you 
were not sick. 
 
Diet  
How many of the last SEVEN DAYS have you followed a healthful eating plan?  
0 1 2 3 4 5 6 7 
On average, over the past month, how many DAYS PER WEEK have you followed your eating 
plan?  
0 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you eat five or more servings of fruits and 
vegetables?  
0 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or full-fat 
dairy products?  
0 1 2 3 4 5 6 7 
Exercise  
On how many of the last SEVEN DAYS did you participate in at least 30 minutes of physical 
activity? (Total minutes of continuous activity, including walking).  
0 1 2 3 4 5 6 7 
Blood Sugar Testing  
On how many of the last SEVEN DAYS did you test your blood sugar?  
0 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you test your blood sugar the number of times 
recommended by your health care  
provider?  
0 1 2 3 4 5 6 7 
Foot Care  
On how many of the last SEVEN DAYS did you check your feet?  
0 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you inspect the inside of your shoes?  
0 1 2 3 4 5 6 7 
Smoking  
Have you smoked a cigarette—even one puff—during the past SEVEN DAYS?  
0. No  
1. Yes. If yes, how many cigarettes did you smoke on an average day?  
Number of cigarettes: 
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Appendix F.  Responses to Stress Questionnaire – Diabetes (RSQ) 
RESPONSES TO STRESS 
 
Part I  
1. Diabetes can be stressful to patients in many different ways.  Please place a check mark next to 
any of the following that have been a problem for you in the last six months. 
 
 Effects of my diabetes on the people I care about 
 Fear of an episode of low blood sugar. 
 Uncertainty regarding my health in the future (e.g., heart disease, high blood pressure) 
 Worries about possible long-term complications of diabetes (e.g. kidney failure, blindness, 
amputations) 
 Concerns about diabetes affecting my finances (e.g. costs of medications, supplies, food) 
 Concerns about diabetes affecting my job (e.g., missing work for doctor’s appointments ) 
 Feelings of guilt (e.g., did I cause my diabetes) 
 Difficulty eating the right foods 
 Difficulty losing or maintaining my weight  
 Having diabetes get in the way of my personal goals or social activities 
 Dealing with diabetes care (e.g. checking blood sugar, taking supplies wherever I go) 
 Feeling upset about high or low blood sugar readings or “bad numbers” 
 
2. Circle the number that shows how stressful these problems were for you. 
1 2 3 4 
Not at all A little Somewhat Very 
 
3. Circle the number that shows how much control you think you have over these problems. 
1 2 3 4 
None A little Some A lot 
 
Part II 
The following is a list of things that people sometimes do, think, or feel in response to problems related to 
diabetes.  Everyone deals with problems in their own way – some people use several of these coping 
techniques or have many of these feelings, other people just do or think a few. 
 
Think of the situations you just checked off in Part I.  For each item on the list below, circle one 
number from 1 (not at all) to 4 (a lot) that shows how much you do or feel these things when dealing with 
problems related to diabetes like the ones you just checked off.  Please let us know about everything you 
do, think, and feel, even if you don’t think it helps make things better. 
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How much do you do this? 
 
N
o
t 
at
 a
ll
 
A
 l
it
tl
e 
S
o
m
e 
A
 l
o
t 
 
  
1. I try NOT to have negative feelings (e.g., sad, worried, angry) about it. 
 
1 2 3 4 
2. When I have problems with my diabetes, I feel sick to my stomach or get headaches. 
 
1 2 3 4 
3. I try to think of different ways to deal with problems related to diabetes.  One plan I 
thought of was: (write in below) 
____________________________________________________________________
____________________________________________________________________
______________________________________ 
 
1 2 3 4 
4. When problems with diabetes come up, I don’t feel anything at all, it’s as if I have no 
feelings. 
 
1 2 3 4 
5. I wish that I were stronger, or better able to cope so that things would be different. 
 
1 2 3 4 
6. I keep remembering what is happening with my diabetes or can’t stop thinking about 
what might happen. 
 
1 2 3 4 
7. I let someone know how I feel. (remember to circle a number)  
Check all that you talked to:   
1 2 3 4 
 Spouse/Partner 
 Brother/Sister 
 Friend 
 
 My children 
 Parent 
 Physician 
 Nurse 
 Therapist/Counselor 
 Another person with 
diabetes 
 
 God 
 None of 
these 
 
8. I decide I’m okay the way I am, even though I’m not perfect. 1 
 
2 
 
3 
 
4 
 
9. When I am around other people I act like the problems with diabetes never happened. 
 
1 2 3 4 
10.   I just have to get away from everything when I have problems with diabetes, I can’t 
stop myself.   
 
1 2 3 4 
11.   I deal with problems related to diabetes by wishing they would just go away, that 
everything would work itself out. 
 
1 2 3 4 
12.   I get easily agitated and jumpy when I am having problems with diabetes.  
 
1 2 3 4 
13.   I realize that I just have to accept things the way they are. 1 2 3 4 
 
14.   When I am struggling with issues related to diabetes, I just can’t be near anything 
that reminds me of the situation. 
 
1 2 3 4 
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15.   I try not to think about it, to forget all about it. 1 2 3 4 
 
16.   When I’m having problems with diabetes, I really don’t know what I feel. 1 2 3 4 
 
 
17.   I ask someone for help or for ideas about how to make the problem better.  
(remember to circle a number)                      
Check all that you talked to: 
1 2 3 4 
 
 
 Spouse/Partner 
 Brother/Sister 
 Friend 
 
 My children 
 Parent 
 Physician 
 Therapist/Counselor 
 Another person with 
diabetes 
 Nurse 
 God 
 None of 
these 
18.   When I am having problems with diabetes, I can’t stop thinking about the problems 
when I try to sleep, or I have nightmares about them. 
1 
 
 
2 3 4 
19.   I tell myself that I can get through this, that I will be okay. 
 
1 
 
2 3 4 
20.  I let my feelings out.  (remember to circle a number)                  
I do this by: (check all that you did) 
1 
 
2 3 4 
Writing in my journal/diary 
Complaining to let off steam 
Listening to music 
Drawing/painting 
Punching a pillow 
Exercising 
 
 
Yelling 
Crying 
None of these 
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21.  I get help from someone when I’m trying to figure out how to deal with my 
feelings.(remember to circle a number) 
Check all that you went to: 
1 2 3 4 
 Spouse/Partner 
 Brother/Sister 
 Friend 
 My children 
 Parent 
 Physician 
 Therapist/Counselor 
 Another person with 
diabetes 
 
 Nurse 
 God 
 None of 
these 
22.  I just can’t get myself to face diabetes when I’m having problems with it. 1 
 
2 3 4 
23.  I wish that someone or something would just come and get me out of this mess. 
 
1 
 
2 3 4 
24.  I do something to try to fix the problems related to diabetes or take action to change 
things. 
One thing I did was: (write in below) 
_________________________________________________________________
_____________________________________________ 
1 
 
 
 
 
 
2 
 
3 4 
25.  Thoughts about diabetes-related issues just pop into my head. 1 
 
2 3 4 
26.  When I have problems with diabetes, I feel it in my body.   (remember to circle a 
number) 
Check all that happen: 
1 
 
 
2 3 4 
 My heart races 
 I feel hot or sweaty 
 My breathing speeds up 
 My muscles get tight 
 None of these 
 
 
 
 
   
27.  I try to stay away from people and things that make me feel upset or    remind me of 
my problems with diabetes. 
1 
 
 
2 3 4 
28.  I don’t feel like myself when I have problems with diabetes, it’s like I’m far away 
from everything. 
1 
 
 
2 3 4 
29.  I just take things as they are, I go with the flow. 1 
 
2 3 4 
30.  I think about happy things to take my mind off the problems or how I’m feeling. 1 
 
 
2 3 4 
31.  When problems related to diabetes come up, I can’t stop thinking about my feelings. 
 
1 
 
 
2 3 4 
32.  I get sympathy, understanding, or support from someone. 
Check all you went to:  (remember to circle a number) 
1 
 
2 3 4 
 
 Spouse/Partner 
 Brother/Sister 
 Friend 
 
 My children 
 Parent 
 Physician 
 Nurse 
 Therapist/Co
unselor 
 Another 
person w/ 
diabetes 
 God 
 None of these 
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33.  When problems with diabetes happen, I can’t always control what I do.  (remember 
to circle a number) 
Check all that happen: 
1 2 3 4 
 
 
 I can’t stop talking 
 I can’t stop eating 
 I have to keep fixing/checking things 
 
 I do dangerous things 
 None of these 
    
34.  I tell myself that things could be worse. 1 2 3 4 
 
35.  My mind just goes blank when I encounter diabetes-related problems,  
      I can’t think at all. 
1 2 3 4 
 
 
36.  I tell myself that it doesn’t matter, that it isn’t a big deal. 1 2 3 4 
 
37.  When I have problems with diabetes, right away I feel very:  (remember to circle a 
number) 
Check all that you feel: 
1 2 3 4 
 
 
 Angry 
 Sad 
 Scared 
 Worried/Anxious 
 None of 
these 
    
38.  It’s really hard for me to concentrate or pay attention when problems with diabetes 
come up. 
1 2 3 4 
 
 
39.  I think about the things I’m learning from the situation, or something good that will 
come from it. 
 
 
1 2 3 4 
 
 
40.  When I have problems with diabetes, I can’t stop thinking about what I did or said. 1 2 3 4 
 
 
41.  When problems with diabetes come up, I say to myself, “this isn’t real.” 1 2 3 4 
 
 
42.  When something goes wrong with diabetes, I end up just lying around or sleeping a 
lot. 
1 2 3 4 
 
 
43.  I keep my mind off my troubles by:  (remember to circle a number) 
Check all that you do: 
1 2 3 4 
 
 Exercising 
 Doing a hobby 
 Reading 
 Seeing friends 
 Watching TV 
 Working 
 Shopping 
 Listening to 
music 
 None of these 
 
 
 
   
 
44.  When problems with diabetes come up, I get more easily upset by things that don’t 
usually bother me. 
 
 
1 
 
 
2 
  
 
3 
 
4 
 
45.  I do something to calm myself down when I am dealing with issues related to 
diabetes. (remember to circle a number) 
Check all that you do: 
  
1 
 
2 
 
3 
 
4 
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 Take deep breaths 
 Listen to music 
 Pray 
 Take a break 
 Walk 
 Meditate 
 None of 
these 
 
 
46.  I just freeze up when I have problems with diabetes, I can’t do anything. 1 
 
 
2 3 4 
47.  When I have problems with diabetes, sometimes I act without thinking. 
 
1 
 
2 3 4 
48.  I keep my feelings under control when I have to, then let them out when they won’t 
make things worse. 
 
1 
 
2 3 4 
49.  When problems related to diabetes come up, I can’t seem to get around to doing 
things I’m supposed to do. 
1 
 
2 3 4 
 
 
50.  I tell myself that everything will be all right. 1 
 
2 3 4 
51.  When I have problems with diabetes, I can’t stop thinking about why they happened 
to me. 
1 
 
2 3 4 
 
 
52.  I think of ways to laugh about it so that it won’t seem so bad. 1 
 
2 3 4 
53.  My thoughts start racing when I’m having a tough time with diabetes. 1 
 
2 3 4 
 
 
54.  I imagine something really fun or exciting happening in my life. 1 
 
2 3 4 
55.  When a rough situation related to diabetes happens, I can get so upset that I can’t 
remember what happened or what I did. 
1 
 
2 3 4 
 
 
56.  I try to believe it never happened. 1 
 
2 3 4 
57.  When I am having problems with diabetes, sometimes I can’t control what I do or 
say. 
1 
 
2 3 4 
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Appendix G.   Problem Areas in Diabetes (PAID) 
DIRECTION: Living with diabetes can sometimes be difficult. In day-to-day life, there may be 
numerous problems and hassles concerning diabetes and they can vary greatly in severity. 
Problems may range from minor hassles to major life difficulties. Listed below are 28 potential 
problem areas which people with diabetes may experience. Consider the degree to which each of 
the items may have distressed or bothered you DURING THE PAST MONTH and circle the 
appropriate number. 
 
Please note that we are asking you to indicate the degree to which each item may be bothering 
you in your life, NOT whether the item is merely true for you. If you feel that a particular item is 
not a bother or a problem for you, you would circle "1". If it is very bothersome to you, you 
might circle "6". 
 
1. Feeling that diabetes is taking up too much of my mental and physical energy every day. 
2. Feeling that my doctor doesn't know enough about diabetes and diabetes care. 
3. Feeling that I can't control my eating.  
4. Feeling that there is no one in my life with whom I can talk really openly about my feelings about 
diabetes. 
5. Worrying about the future and the possibility that I could develop serious long-term 
complications 
6. Feeling that I don't see my doctor often or long enough.  
7. Feeling that I am not getting enough physical exercise.  
8. Feeling that I have to hide my diabetes from others.  
9. Feeling angry, scared and/or depressed when I think about living with diabetes. 
10. Feeling that my doctor doesn't give me clear enough directions on how to manage my diabetes. 
11. Feeling that I am not testing my blood sugars frequently enough. 
12. Feeling that friends or family act like "diabetes police" (e.g. nag about eating properly, testing 
blood sugars, not trying hard enough). 
13. Feeling "burned out" by the constant effort to manage diabetes. 
14. Feeling that I can't tell my doctor what is really on my mind. 
15. Feeling that I am often failing with my diabetes regimen.  
16. Feeling that friends or family are not supportive enough of my self-care efforts (e.g. planning  
activities that conflict with my schedule, encouraging me to eat the "wrong" foods). 
17. Feeling that diabetes controls my life.  
18. Feeling that my doctor doesn't take my concerns seriously enough. 
19. Not feeling confident in my day-to-day ability to manage diabetes. 
20. Worrying that diabetes limits my social relationships and friendships. 
21. Feeling that I will end up with serious long-term complications, no matter what I do. 
22. Feeling that my doctor doesn't really understand what it's like to have diabetes. 
23. Feeling that I am not sticking closely enough to a good meal plan. 
24. Feeling that friends or family don't appreciate how difficult living with diabetes can be. 
25. Feeling overwhelmed by the demands of living with diabetes. 
26. Feeling that I don't have a doctor who I can see regularly about my diabetes. 
27. Not feeling motivated to keep up my diabetes self-management. 
28. Feeling that friends or family don't give me the emotional support that I would like. 
 
